Global Coagulation Factor IV Supply, Demand and Key Producers, 2026-2032
The global Coagulation Factor IV market size is expected to reach $ 380 million by 2032, rising at a market growth of 5.1% CAGR during the forecast period (2026-2032).
Coagulation Factor IV is the traditional coagulation-system name for the clotting function of calcium ion rather than a human-derived protein, plasma fraction, or recombinant coagulation factor drug. Its active entity is free calcium ion, which is generally not sold as an isolated standalone solid or liquid product. In commercial practice, Coagulation Factor IV-related products are delivered through calcium chloride, calcium gluconate, compound electrolyte solutions, assay reagents, calibrators, or research-grade calcium salts. These products may appear as clear and colorless injectable solutions, prefilled syringes, ampoules, infusion bags, white crystalline powders, granules, flakes, or standard solutions, with the essential composition being calcium salts capable of releasing calcium ions in aqueous systems. Major applications include correction of hypocalcemia, emergency calcium replacement, infusion and dialysis formulations, coagulation research, cell culture, assay calibration, and related industrial formulations.
The market opportunity for this product mainly comes from stable demand in clinical electrolyte management, emergency care, dialysis treatment, injectable-drug supply security, and laboratory testing. Aging populations, the rising prevalence of chronic kidney disease, the expansion of intensive-care capacity, and hospitals’ reliance on standardized injectable preparations support resilient demand for pharmaceutical-grade calcium-source products. On the research and diagnostic side, coagulation studies, cell culture, ion measurement, quality control, and in vitro experimental systems create a specialized but steady demand base. Because the active entity is not a high-barrier protein biologic, growth is driven more by standardization, sterility, supply-chain reliability, and pharmacopeial compliance than by innovative-drug pricing power.
The main risk is the potential misclassification of the product category. Treating Coagulation Factor IV as a human-derived coagulation factor or recombinant coagulation factor drug would distort market sizing, competitive mapping, and manufacturer screening. Calcium salt products have lower technical barriers than biologics, while industrial-grade products are exposed to commodity price fluctuations. Pharmaceutical-grade products are constrained by registration requirements, sterile manufacturing, quality consistency, procurement pricing, impurity limits, and recall risks. For injectable-drug manufacturers, production capability depends not only on chemical formulation but also on aseptic filling lines, quality systems, regulatory compliance, and reliable supply. For research-reagent suppliers, brand credibility, purity, batch-to-batch consistency, and certification systems are the key competitive factors.
Downstream demand is expected to become more segmented. Clinical users will increasingly prefer standardized, ready-to-use, small-volume, prefilled, and pharmacy-friendly presentations. Dialysis and infusion markets will continue to use compound electrolyte products, but calcium salts in these formulations function more as components than as standalone high-value products. Research and diagnostic customers will place greater emphasis on high purity, low impurity profiles, traceable lot numbers, and stable calibration systems. Bulk industrial calcium salts will remain large in volume, but their pricing and application logic have limited relevance to the coagulation function and should not be merged into the core market for this topic. Overall, this is not a high-growth innovation market; it is a stable, regulated, and definition-sensitive market for basic pharmaceutical and laboratory materials.
This report studies the global Coagulation Factor IV production, demand, key manufacturers, and key regions.
This report is a detailed and comprehensive analysis of the world market for Coagulation Factor IV and provides market size (US$ million) and Year-over-Year (YoY) Growth, considering 2025 as the base year. This report explores demand trends and competition, as well as details the characteristics of Coagulation Factor IV that contribute to its increasing demand across many markets.
Highlights and key features of the study
Global Coagulation Factor IV total production and demand, 2021-2032, (K Dose)
Global Coagulation Factor IV total production value, 2021-2032, (USD Million)
Global Coagulation Factor IV production by region & country, production, value, CAGR, 2021-2032, (USD Million) & (K Dose), (based on production site)
Global Coagulation Factor IV consumption by region & country, CAGR, 2021-2032 & (K Dose)
U.S. VS China: Coagulation Factor IV domestic production, consumption, key domestic manufacturers and share
Global Coagulation Factor IV production by manufacturer, production, price, value and market share 2021-2026, (USD Million) & (K Dose)
Global Coagulation Factor IV production by Type, production, value, CAGR, 2021-2032, (USD Million) & (K Dose)
Global Coagulation Factor IV production by Application, production, value, CAGR, 2021-2032, (USD Million) & (K Dose)
This report profiles key players in the global Coagulation Factor IV market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Pfizer, Baxter, Fresenius Kabi, B. Braun, Hikma, Amneal, Dr. Reddy’s, American Regent, Amphastar, Civica, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Coagulation Factor IV market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), volume (production, consumption) & (K Dose) and average price (USD/Pcs) by manufacturer, by Type, and by Application. Data is given for the years 2021-2032 by year with 2025 as the base year, 2026 as the estimate year, and 2027-2032 as the forecast year.
Global Coagulation Factor IV Market, By Region:
1. How big is the global Coagulation Factor IV market?
2. What is the demand of the global Coagulation Factor IV market?
3. What is the year over year growth of the global Coagulation Factor IV market?
4. What is the production and production value of the global Coagulation Factor IV market?
5. Who are the key producers in the global Coagulation Factor IV market?
6. What are the growth factors driving the market demand?
Coagulation Factor IV is the traditional coagulation-system name for the clotting function of calcium ion rather than a human-derived protein, plasma fraction, or recombinant coagulation factor drug. Its active entity is free calcium ion, which is generally not sold as an isolated standalone solid or liquid product. In commercial practice, Coagulation Factor IV-related products are delivered through calcium chloride, calcium gluconate, compound electrolyte solutions, assay reagents, calibrators, or research-grade calcium salts. These products may appear as clear and colorless injectable solutions, prefilled syringes, ampoules, infusion bags, white crystalline powders, granules, flakes, or standard solutions, with the essential composition being calcium salts capable of releasing calcium ions in aqueous systems. Major applications include correction of hypocalcemia, emergency calcium replacement, infusion and dialysis formulations, coagulation research, cell culture, assay calibration, and related industrial formulations.
The market opportunity for this product mainly comes from stable demand in clinical electrolyte management, emergency care, dialysis treatment, injectable-drug supply security, and laboratory testing. Aging populations, the rising prevalence of chronic kidney disease, the expansion of intensive-care capacity, and hospitals’ reliance on standardized injectable preparations support resilient demand for pharmaceutical-grade calcium-source products. On the research and diagnostic side, coagulation studies, cell culture, ion measurement, quality control, and in vitro experimental systems create a specialized but steady demand base. Because the active entity is not a high-barrier protein biologic, growth is driven more by standardization, sterility, supply-chain reliability, and pharmacopeial compliance than by innovative-drug pricing power.
The main risk is the potential misclassification of the product category. Treating Coagulation Factor IV as a human-derived coagulation factor or recombinant coagulation factor drug would distort market sizing, competitive mapping, and manufacturer screening. Calcium salt products have lower technical barriers than biologics, while industrial-grade products are exposed to commodity price fluctuations. Pharmaceutical-grade products are constrained by registration requirements, sterile manufacturing, quality consistency, procurement pricing, impurity limits, and recall risks. For injectable-drug manufacturers, production capability depends not only on chemical formulation but also on aseptic filling lines, quality systems, regulatory compliance, and reliable supply. For research-reagent suppliers, brand credibility, purity, batch-to-batch consistency, and certification systems are the key competitive factors.
Downstream demand is expected to become more segmented. Clinical users will increasingly prefer standardized, ready-to-use, small-volume, prefilled, and pharmacy-friendly presentations. Dialysis and infusion markets will continue to use compound electrolyte products, but calcium salts in these formulations function more as components than as standalone high-value products. Research and diagnostic customers will place greater emphasis on high purity, low impurity profiles, traceable lot numbers, and stable calibration systems. Bulk industrial calcium salts will remain large in volume, but their pricing and application logic have limited relevance to the coagulation function and should not be merged into the core market for this topic. Overall, this is not a high-growth innovation market; it is a stable, regulated, and definition-sensitive market for basic pharmaceutical and laboratory materials.
This report studies the global Coagulation Factor IV production, demand, key manufacturers, and key regions.
This report is a detailed and comprehensive analysis of the world market for Coagulation Factor IV and provides market size (US$ million) and Year-over-Year (YoY) Growth, considering 2025 as the base year. This report explores demand trends and competition, as well as details the characteristics of Coagulation Factor IV that contribute to its increasing demand across many markets.
Highlights and key features of the study
Global Coagulation Factor IV total production and demand, 2021-2032, (K Dose)
Global Coagulation Factor IV total production value, 2021-2032, (USD Million)
Global Coagulation Factor IV production by region & country, production, value, CAGR, 2021-2032, (USD Million) & (K Dose), (based on production site)
Global Coagulation Factor IV consumption by region & country, CAGR, 2021-2032 & (K Dose)
U.S. VS China: Coagulation Factor IV domestic production, consumption, key domestic manufacturers and share
Global Coagulation Factor IV production by manufacturer, production, price, value and market share 2021-2026, (USD Million) & (K Dose)
Global Coagulation Factor IV production by Type, production, value, CAGR, 2021-2032, (USD Million) & (K Dose)
Global Coagulation Factor IV production by Application, production, value, CAGR, 2021-2032, (USD Million) & (K Dose)
This report profiles key players in the global Coagulation Factor IV market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Pfizer, Baxter, Fresenius Kabi, B. Braun, Hikma, Amneal, Dr. Reddy’s, American Regent, Amphastar, Civica, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Coagulation Factor IV market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), volume (production, consumption) & (K Dose) and average price (USD/Pcs) by manufacturer, by Type, and by Application. Data is given for the years 2021-2032 by year with 2025 as the base year, 2026 as the estimate year, and 2027-2032 as the forecast year.
Global Coagulation Factor IV Market, By Region:
- United States
- China
- Europe
- Japan
- South Korea
- ASEAN
- India
- Rest of World
- alcium Chloride-based Products
- Calcium Gluconate-based Products
- Others
- Finished Drug Products
- Hospital Preparations or Compounded Products
- Others
- Powder or Crystalline Products
- Granular Products
- Flake Products
- Hospital
- Personal Clinic
- Others
- Pfizer
- Baxter
- Fresenius Kabi
- B. Braun
- Hikma
- Amneal
- Dr. Reddy’s
- American Regent
- Amphastar
- Civica
- hameln pharma
- Medefil
- OxyChem
- TETRA Technologies
- Tata Chemicals Europe
- Zirax
- Tokuyama
- Merck KGaA
- Thermo Fisher Scientific
- Avantor
- FUJIFILM Wako Pure Chemical
- Tokyo Chemical Industry
- Kanto Chemical
- Nacalai Tesque
- Spectrum Chemical
- American Elements
- Columbus Chemical Industries
- Zhejiang Ruibang Pharmaceutical
- Hebei Tiancheng Pharmaceutical
- CR Double-Crane Limin Pharmaceutical
- Jiangsu Hengrui Pharmaceuticals
- Shandong Haihua
- Shandong Haihua New Materials
1. How big is the global Coagulation Factor IV market?
2. What is the demand of the global Coagulation Factor IV market?
3. What is the year over year growth of the global Coagulation Factor IV market?
4. What is the production and production value of the global Coagulation Factor IV market?
5. Who are the key producers in the global Coagulation Factor IV market?
6. What are the growth factors driving the market demand?
1 SUPPLY SUMMARY
1.1 Coagulation Factor IV Introduction
1.2 World Coagulation Factor IV Supply & Forecast
1.2.1 World Coagulation Factor IV Production Value (2021 & 2025 & 2032)
1.2.2 World Coagulation Factor IV Production (2021-2032)
1.2.3 World Coagulation Factor IV Pricing Trends (2021-2032)
1.3 World Coagulation Factor IV Production by Region (Based on Production Site)
1.3.1 World Coagulation Factor IV Production Value by Region (2021-2032)
1.3.2 World Coagulation Factor IV Production by Region (2021-2032)
1.3.3 World Coagulation Factor IV Average Price by Region (2021-2032)
1.3.4 North America Coagulation Factor IV Production (2021-2032)
1.3.5 Europe Coagulation Factor IV Production (2021-2032)
1.3.6 China Coagulation Factor IV Production (2021-2032)
1.3.7 Japan Coagulation Factor IV Production (2021-2032)
1.3.8 India Coagulation Factor IV Production (2021-2032)
1.3.9 Southeast Asia Coagulation Factor IV Production (2021-2032)
1.4 Market Drivers, Restraints and Trends
1.4.1 Coagulation Factor IV Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 Coagulation Factor IV Major Market Trends
2 DEMAND SUMMARY
2.1 World Coagulation Factor IV Demand (2021-2032)
2.2 World Coagulation Factor IV Consumption by Region
2.2.1 World Coagulation Factor IV Consumption by Region (2021-2026)
2.2.2 World Coagulation Factor IV Consumption Forecast by Region (2027-2032)
2.3 United States Coagulation Factor IV Consumption (2021-2032)
2.4 China Coagulation Factor IV Consumption (2021-2032)
2.5 Europe Coagulation Factor IV Consumption (2021-2032)
2.6 Japan Coagulation Factor IV Consumption (2021-2032)
2.7 South Korea Coagulation Factor IV Consumption (2021-2032)
2.8 ASEAN Coagulation Factor IV Consumption (2021-2032)
2.9 India Coagulation Factor IV Consumption (2021-2032)
3 WORLD MANUFACTURERS COMPETITIVE ANALYSIS
3.1 World Coagulation Factor IV Production Value by Manufacturer (2021-2026)
3.2 World Coagulation Factor IV Production by Manufacturer (2021-2026)
3.3 World Coagulation Factor IV Average Price by Manufacturer (2021-2026)
3.4 Coagulation Factor IV Company Evaluation Quadrant
3.5 Industry Rank and Concentration Rate (CR)
3.5.1 Global Coagulation Factor IV Industry Rank of Major Manufacturers
3.5.2 Global Concentration Ratios (CR4) for Coagulation Factor IV in 2025
3.5.3 Global Concentration Ratios (CR8) for Coagulation Factor IV in 2025
3.6 Coagulation Factor IV Market: Overall Company Footprint Analysis
3.6.1 Coagulation Factor IV Market: Region Footprint
3.6.2 Coagulation Factor IV Market: Company Product Type Footprint
3.6.3 Coagulation Factor IV Market: Company Product Application Footprint
3.7 Competitive Environment
3.7.1 Historical Structure of the Industry
3.7.2 Barriers of Market Entry
3.7.3 Factors of Competition
3.8 New Entrant and Capacity Expansion Plans
3.9 Mergers, Acquisition, Agreements, and Collaborations
4 UNITED STATES VS CHINA VS REST OF THE WORLD
4.1 United States VS China: Coagulation Factor IV Production Value Comparison
4.1.1 United States VS China: Coagulation Factor IV Production Value Comparison (2021 & 2025 & 2032)
4.1.2 United States VS China: Coagulation Factor IV Production Value Market Share Comparison (2021 & 2025 & 2032)
4.2 United States VS China: Coagulation Factor IV Production Comparison
4.2.1 United States VS China: Coagulation Factor IV Production Comparison (2021 & 2025 & 2032)
4.2.2 United States VS China: Coagulation Factor IV Production Market Share Comparison (2021 & 2025 & 2032)
4.3 United States VS China: Coagulation Factor IV Consumption Comparison
4.3.1 United States VS China: Coagulation Factor IV Consumption Comparison (2021 & 2025 & 2032)
4.3.2 United States VS China: Coagulation Factor IV Consumption Market Share Comparison (2021 & 2025 & 2032)
4.4 United States Based Coagulation Factor IV Manufacturers and Market Share, 2021-2026
4.4.1 United States Based Coagulation Factor IV Manufacturers, Headquarters and Production Site (States, Country)
4.4.2 United States Based Manufacturers Coagulation Factor IV Production Value (2021-2026)
4.4.3 United States Based Manufacturers Coagulation Factor IV Production (2021-2026)
4.5 China Based Coagulation Factor IV Manufacturers and Market Share
4.5.1 China Based Coagulation Factor IV Manufacturers, Headquarters and Production Site (Province, Country)
4.5.2 China Based Manufacturers Coagulation Factor IV Production Value (2021-2026)
4.5.3 China Based Manufacturers Coagulation Factor IV Production (2021-2026)
4.6 Rest of World Based Coagulation Factor IV Manufacturers and Market Share, 2021-2026
4.6.1 Rest of World Based Coagulation Factor IV Manufacturers, Headquarters and Production Site (State, Country)
4.6.2 Rest of World Based Manufacturers Coagulation Factor IV Production Value (2021-2026)
4.6.3 Rest of World Based Manufacturers Coagulation Factor IV Production (2021-2026)
5 MARKET ANALYSIS BY TYPE
5.1 World Coagulation Factor IV Market Size Overview by Type: 2021 VS 2025 VS 2032
5.2 Segment Introduction by Type
5.2.1 alcium Chloride-based Products
5.2.2 Calcium Gluconate-based Products
5.2.3 Others
5.3 Market Segment by Type
5.3.1 World Coagulation Factor IV Production by Type (2021-2032)
5.3.2 World Coagulation Factor IV Production Value by Type (2021-2032)
5.3.3 World Coagulation Factor IV Average Price by Type (2021-2032)
6 MARKET ANALYSIS BY PHARMACEUTICAL PRODUCT FORM
6.1 World Coagulation Factor IV Market Size Overview by Pharmaceutical Product Form: 2021 VS 2025 VS 2032
6.2 Segment Introduction by Pharmaceutical Product Form
6.2.1 Finished Drug Products
6.2.2 Hospital Preparations or Compounded Products
6.2.3 Others
6.3 Market Segment by Pharmaceutical Product Form
6.3.1 World Coagulation Factor IV Production by Pharmaceutical Product Form (2021-2032)
6.3.2 World Coagulation Factor IV Production Value by Pharmaceutical Product Form (2021-2032)
6.3.3 World Coagulation Factor IV Average Price by Pharmaceutical Product Form (2021-2032)
7 MARKET ANALYSIS BY SOLID MORPHOLOGY
7.1 World Coagulation Factor IV Market Size Overview by Solid Morphology: 2021 VS 2025 VS 2032
7.2 Segment Introduction by Solid Morphology
7.2.1 Powder or Crystalline Products
7.2.2 Granular Products
7.2.3 Flake Products
7.3 Market Segment by Solid Morphology
7.3.1 World Coagulation Factor IV Production by Solid Morphology (2021-2032)
7.3.2 World Coagulation Factor IV Production Value by Solid Morphology (2021-2032)
7.3.3 World Coagulation Factor IV Average Price by Solid Morphology (2021-2032)
8 MARKET ANALYSIS BY APPLICATION
8.1 World Coagulation Factor IV Market Size Overview by Application: 2021 VS 2025 VS 2032
8.2 Segment Introduction by Application
8.2.1 Hospital
8.2.2 Personal Clinic
8.2.3 Others
8.3 Market Segment by Application
8.3.1 World Coagulation Factor IV Production by Application (2021-2032)
8.3.2 World Coagulation Factor IV Production Value by Application (2021-2032)
8.3.3 World Coagulation Factor IV Average Price by Application (2021-2032)
9 COMPANY PROFILES
9.1 Pfizer
9.1.1 Pfizer Details
9.1.2 Pfizer Major Business
9.1.3 Pfizer Coagulation Factor IV Product and Services
9.1.4 Pfizer Coagulation Factor IV Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.1.5 Pfizer Recent Developments/Updates
9.1.6 Pfizer Competitive Strengths & Weaknesses
9.2 Baxter
9.2.1 Baxter Details
9.2.2 Baxter Major Business
9.2.3 Baxter Coagulation Factor IV Product and Services
9.2.4 Baxter Coagulation Factor IV Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.2.5 Baxter Recent Developments/Updates
9.2.6 Baxter Competitive Strengths & Weaknesses
9.3 Fresenius Kabi
9.3.1 Fresenius Kabi Details
9.3.2 Fresenius Kabi Major Business
9.3.3 Fresenius Kabi Coagulation Factor IV Product and Services
9.3.4 Fresenius Kabi Coagulation Factor IV Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.3.5 Fresenius Kabi Recent Developments/Updates
9.3.6 Fresenius Kabi Competitive Strengths & Weaknesses
9.4 B. Braun
9.4.1 B. Braun Details
9.4.2 B. Braun Major Business
9.4.3 B. Braun Coagulation Factor IV Product and Services
9.4.4 B. Braun Coagulation Factor IV Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.4.5 B. Braun Recent Developments/Updates
9.4.6 B. Braun Competitive Strengths & Weaknesses
9.5 Hikma
9.5.1 Hikma Details
9.5.2 Hikma Major Business
9.5.3 Hikma Coagulation Factor IV Product and Services
9.5.4 Hikma Coagulation Factor IV Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.5.5 Hikma Recent Developments/Updates
9.5.6 Hikma Competitive Strengths & Weaknesses
9.6 Amneal
9.6.1 Amneal Details
9.6.2 Amneal Major Business
9.6.3 Amneal Coagulation Factor IV Product and Services
9.6.4 Amneal Coagulation Factor IV Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.6.5 Amneal Recent Developments/Updates
9.6.6 Amneal Competitive Strengths & Weaknesses
9.7 Dr. Reddy’s
9.7.1 Dr. Reddy’s Details
9.7.2 Dr. Reddy’s Major Business
9.7.3 Dr. Reddy’s Coagulation Factor IV Product and Services
9.7.4 Dr. Reddy’s Coagulation Factor IV Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.7.5 Dr. Reddy’s Recent Developments/Updates
9.7.6 Dr. Reddy’s Competitive Strengths & Weaknesses
9.8 American Regent
9.8.1 American Regent Details
9.8.2 American Regent Major Business
9.8.3 American Regent Coagulation Factor IV Product and Services
9.8.4 American Regent Coagulation Factor IV Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.8.5 American Regent Recent Developments/Updates
9.8.6 American Regent Competitive Strengths & Weaknesses
9.9 Amphastar
9.9.1 Amphastar Details
9.9.2 Amphastar Major Business
9.9.3 Amphastar Coagulation Factor IV Product and Services
9.9.4 Amphastar Coagulation Factor IV Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.9.5 Amphastar Recent Developments/Updates
9.9.6 Amphastar Competitive Strengths & Weaknesses
9.10 Civica
9.10.1 Civica Details
9.10.2 Civica Major Business
9.10.3 Civica Coagulation Factor IV Product and Services
9.10.4 Civica Coagulation Factor IV Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.10.5 Civica Recent Developments/Updates
9.10.6 Civica Competitive Strengths & Weaknesses
9.11 hameln pharma
9.11.1 hameln pharma Details
9.11.2 hameln pharma Major Business
9.11.3 hameln pharma Coagulation Factor IV Product and Services
9.11.4 hameln pharma Coagulation Factor IV Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.11.5 hameln pharma Recent Developments/Updates
9.11.6 hameln pharma Competitive Strengths & Weaknesses
9.12 Medefil
9.12.1 Medefil Details
9.12.2 Medefil Major Business
9.12.3 Medefil Coagulation Factor IV Product and Services
9.12.4 Medefil Coagulation Factor IV Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.12.5 Medefil Recent Developments/Updates
9.12.6 Medefil Competitive Strengths & Weaknesses
9.13 OxyChem
9.13.1 OxyChem Details
9.13.2 OxyChem Major Business
9.13.3 OxyChem Coagulation Factor IV Product and Services
9.13.4 OxyChem Coagulation Factor IV Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.13.5 OxyChem Recent Developments/Updates
9.13.6 OxyChem Competitive Strengths & Weaknesses
9.14 TETRA Technologies
9.14.1 TETRA Technologies Details
9.14.2 TETRA Technologies Major Business
9.14.3 TETRA Technologies Coagulation Factor IV Product and Services
9.14.4 TETRA Technologies Coagulation Factor IV Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.14.5 TETRA Technologies Recent Developments/Updates
9.14.6 TETRA Technologies Competitive Strengths & Weaknesses
9.15 Tata Chemicals Europe
9.15.1 Tata Chemicals Europe Details
9.15.2 Tata Chemicals Europe Major Business
9.15.3 Tata Chemicals Europe Coagulation Factor IV Product and Services
9.15.4 Tata Chemicals Europe Coagulation Factor IV Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.15.5 Tata Chemicals Europe Recent Developments/Updates
9.15.6 Tata Chemicals Europe Competitive Strengths & Weaknesses
9.16 Zirax
9.16.1 Zirax Details
9.16.2 Zirax Major Business
9.16.3 Zirax Coagulation Factor IV Product and Services
9.16.4 Zirax Coagulation Factor IV Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.16.5 Zirax Recent Developments/Updates
9.16.6 Zirax Competitive Strengths & Weaknesses
9.17 Tokuyama
9.17.1 Tokuyama Details
9.17.2 Tokuyama Major Business
9.17.3 Tokuyama Coagulation Factor IV Product and Services
9.17.4 Tokuyama Coagulation Factor IV Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.17.5 Tokuyama Recent Developments/Updates
9.17.6 Tokuyama Competitive Strengths & Weaknesses
9.18 Merck KGaA
9.18.1 Merck KGaA Details
9.18.2 Merck KGaA Major Business
9.18.3 Merck KGaA Coagulation Factor IV Product and Services
9.18.4 Merck KGaA Coagulation Factor IV Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.18.5 Merck KGaA Recent Developments/Updates
9.18.6 Merck KGaA Competitive Strengths & Weaknesses
9.19 Thermo Fisher Scientific
9.19.1 Thermo Fisher Scientific Details
9.19.2 Thermo Fisher Scientific Major Business
9.19.3 Thermo Fisher Scientific Coagulation Factor IV Product and Services
9.19.4 Thermo Fisher Scientific Coagulation Factor IV Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.19.5 Thermo Fisher Scientific Recent Developments/Updates
9.19.6 Thermo Fisher Scientific Competitive Strengths & Weaknesses
9.20 Avantor
9.20.1 Avantor Details
9.20.2 Avantor Major Business
9.20.3 Avantor Coagulation Factor IV Product and Services
9.20.4 Avantor Coagulation Factor IV Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.20.5 Avantor Recent Developments/Updates
9.20.6 Avantor Competitive Strengths & Weaknesses
9.21 FUJIFILM Wako Pure Chemical
9.21.1 FUJIFILM Wako Pure Chemical Details
9.21.2 FUJIFILM Wako Pure Chemical Major Business
9.21.3 FUJIFILM Wako Pure Chemical Coagulation Factor IV Product and Services
9.21.4 FUJIFILM Wako Pure Chemical Coagulation Factor IV Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.21.5 FUJIFILM Wako Pure Chemical Recent Developments/Updates
9.21.6 FUJIFILM Wako Pure Chemical Competitive Strengths & Weaknesses
9.22 Tokyo Chemical Industry
9.22.1 Tokyo Chemical Industry Details
9.22.2 Tokyo Chemical Industry Major Business
9.22.3 Tokyo Chemical Industry Coagulation Factor IV Product and Services
9.22.4 Tokyo Chemical Industry Coagulation Factor IV Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.22.5 Tokyo Chemical Industry Recent Developments/Updates
9.22.6 Tokyo Chemical Industry Competitive Strengths & Weaknesses
9.23 Kanto Chemical
9.23.1 Kanto Chemical Details
9.23.2 Kanto Chemical Major Business
9.23.3 Kanto Chemical Coagulation Factor IV Product and Services
9.23.4 Kanto Chemical Coagulation Factor IV Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.23.5 Kanto Chemical Recent Developments/Updates
9.23.6 Kanto Chemical Competitive Strengths & Weaknesses
9.24 Nacalai Tesque
9.24.1 Nacalai Tesque Details
9.24.2 Nacalai Tesque Major Business
9.24.3 Nacalai Tesque Coagulation Factor IV Product and Services
9.24.4 Nacalai Tesque Coagulation Factor IV Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.24.5 Nacalai Tesque Recent Developments/Updates
9.24.6 Nacalai Tesque Competitive Strengths & Weaknesses
9.25 Spectrum Chemical
9.25.1 Spectrum Chemical Details
9.25.2 Spectrum Chemical Major Business
9.25.3 Spectrum Chemical Coagulation Factor IV Product and Services
9.25.4 Spectrum Chemical Coagulation Factor IV Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.25.5 Spectrum Chemical Recent Developments/Updates
9.25.6 Spectrum Chemical Competitive Strengths & Weaknesses
9.26 American Elements
9.26.1 American Elements Details
9.26.2 American Elements Major Business
9.26.3 American Elements Coagulation Factor IV Product and Services
9.26.4 American Elements Coagulation Factor IV Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.26.5 American Elements Recent Developments/Updates
9.26.6 American Elements Competitive Strengths & Weaknesses
9.27 Columbus Chemical Industries
9.27.1 Columbus Chemical Industries Details
9.27.2 Columbus Chemical Industries Major Business
9.27.3 Columbus Chemical Industries Coagulation Factor IV Product and Services
9.27.4 Columbus Chemical Industries Coagulation Factor IV Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.27.5 Columbus Chemical Industries Recent Developments/Updates
9.27.6 Columbus Chemical Industries Competitive Strengths & Weaknesses
9.28 Zhejiang Ruibang Pharmaceutical
9.28.1 Zhejiang Ruibang Pharmaceutical Details
9.28.2 Zhejiang Ruibang Pharmaceutical Major Business
9.28.3 Zhejiang Ruibang Pharmaceutical Coagulation Factor IV Product and Services
9.28.4 Zhejiang Ruibang Pharmaceutical Coagulation Factor IV Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.28.5 Zhejiang Ruibang Pharmaceutical Recent Developments/Updates
9.28.6 Zhejiang Ruibang Pharmaceutical Competitive Strengths & Weaknesses
9.29 Hebei Tiancheng Pharmaceutical
9.29.1 Hebei Tiancheng Pharmaceutical Details
9.29.2 Hebei Tiancheng Pharmaceutical Major Business
9.29.3 Hebei Tiancheng Pharmaceutical Coagulation Factor IV Product and Services
9.29.4 Hebei Tiancheng Pharmaceutical Coagulation Factor IV Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.29.5 Hebei Tiancheng Pharmaceutical Recent Developments/Updates
9.29.6 Hebei Tiancheng Pharmaceutical Competitive Strengths & Weaknesses
9.30 CR Double-Crane Limin Pharmaceutical
9.30.1 CR Double-Crane Limin Pharmaceutical Details
9.30.2 CR Double-Crane Limin Pharmaceutical Major Business
9.30.3 CR Double-Crane Limin Pharmaceutical Coagulation Factor IV Product and Services
9.30.4 CR Double-Crane Limin Pharmaceutical Coagulation Factor IV Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.30.5 CR Double-Crane Limin Pharmaceutical Recent Developments/Updates
9.30.6 CR Double-Crane Limin Pharmaceutical Competitive Strengths & Weaknesses
9.31 Jiangsu Hengrui Pharmaceuticals
9.31.1 Jiangsu Hengrui Pharmaceuticals Details
9.31.2 Jiangsu Hengrui Pharmaceuticals Major Business
9.31.3 Jiangsu Hengrui Pharmaceuticals Coagulation Factor IV Product and Services
9.31.4 Jiangsu Hengrui Pharmaceuticals Coagulation Factor IV Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.31.5 Jiangsu Hengrui Pharmaceuticals Recent Developments/Updates
9.31.6 Jiangsu Hengrui Pharmaceuticals Competitive Strengths & Weaknesses
9.32 Shandong Haihua
9.32.1 Shandong Haihua Details
9.32.2 Shandong Haihua Major Business
9.32.3 Shandong Haihua Coagulation Factor IV Product and Services
9.32.4 Shandong Haihua Coagulation Factor IV Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.32.5 Shandong Haihua Recent Developments/Updates
9.32.6 Shandong Haihua Competitive Strengths & Weaknesses
9.33 Shandong Haihua New Materials
9.33.1 Shandong Haihua New Materials Details
9.33.2 Shandong Haihua New Materials Major Business
9.33.3 Shandong Haihua New Materials Coagulation Factor IV Product and Services
9.33.4 Shandong Haihua New Materials Coagulation Factor IV Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.33.5 Shandong Haihua New Materials Recent Developments/Updates
9.33.6 Shandong Haihua New Materials Competitive Strengths & Weaknesses
10 INDUSTRY CHAIN ANALYSIS
10.1 Coagulation Factor IV Industry Chain
10.2 Coagulation Factor IV Upstream Analysis
10.2.1 Coagulation Factor IV Core Raw Materials
10.2.2 Main Manufacturers of Coagulation Factor IV Core Raw Materials
10.3 Midstream Analysis
10.4 Downstream Analysis
10.5 Coagulation Factor IV Production Mode
10.6 Coagulation Factor IV Procurement Model
10.7 Coagulation Factor IV Industry Sales Model and Sales Channels
10.7.1 Coagulation Factor IV Sales Model
10.7.2 Coagulation Factor IV Typical Distributors
11 RESEARCH FINDINGS AND CONCLUSION
12 APPENDIX
12.1 Methodology
12.2 Research Process and Data Source
12.3 Disclaimer
1.1 Coagulation Factor IV Introduction
1.2 World Coagulation Factor IV Supply & Forecast
1.2.1 World Coagulation Factor IV Production Value (2021 & 2025 & 2032)
1.2.2 World Coagulation Factor IV Production (2021-2032)
1.2.3 World Coagulation Factor IV Pricing Trends (2021-2032)
1.3 World Coagulation Factor IV Production by Region (Based on Production Site)
1.3.1 World Coagulation Factor IV Production Value by Region (2021-2032)
1.3.2 World Coagulation Factor IV Production by Region (2021-2032)
1.3.3 World Coagulation Factor IV Average Price by Region (2021-2032)
1.3.4 North America Coagulation Factor IV Production (2021-2032)
1.3.5 Europe Coagulation Factor IV Production (2021-2032)
1.3.6 China Coagulation Factor IV Production (2021-2032)
1.3.7 Japan Coagulation Factor IV Production (2021-2032)
1.3.8 India Coagulation Factor IV Production (2021-2032)
1.3.9 Southeast Asia Coagulation Factor IV Production (2021-2032)
1.4 Market Drivers, Restraints and Trends
1.4.1 Coagulation Factor IV Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 Coagulation Factor IV Major Market Trends
2 DEMAND SUMMARY
2.1 World Coagulation Factor IV Demand (2021-2032)
2.2 World Coagulation Factor IV Consumption by Region
2.2.1 World Coagulation Factor IV Consumption by Region (2021-2026)
2.2.2 World Coagulation Factor IV Consumption Forecast by Region (2027-2032)
2.3 United States Coagulation Factor IV Consumption (2021-2032)
2.4 China Coagulation Factor IV Consumption (2021-2032)
2.5 Europe Coagulation Factor IV Consumption (2021-2032)
2.6 Japan Coagulation Factor IV Consumption (2021-2032)
2.7 South Korea Coagulation Factor IV Consumption (2021-2032)
2.8 ASEAN Coagulation Factor IV Consumption (2021-2032)
2.9 India Coagulation Factor IV Consumption (2021-2032)
3 WORLD MANUFACTURERS COMPETITIVE ANALYSIS
3.1 World Coagulation Factor IV Production Value by Manufacturer (2021-2026)
3.2 World Coagulation Factor IV Production by Manufacturer (2021-2026)
3.3 World Coagulation Factor IV Average Price by Manufacturer (2021-2026)
3.4 Coagulation Factor IV Company Evaluation Quadrant
3.5 Industry Rank and Concentration Rate (CR)
3.5.1 Global Coagulation Factor IV Industry Rank of Major Manufacturers
3.5.2 Global Concentration Ratios (CR4) for Coagulation Factor IV in 2025
3.5.3 Global Concentration Ratios (CR8) for Coagulation Factor IV in 2025
3.6 Coagulation Factor IV Market: Overall Company Footprint Analysis
3.6.1 Coagulation Factor IV Market: Region Footprint
3.6.2 Coagulation Factor IV Market: Company Product Type Footprint
3.6.3 Coagulation Factor IV Market: Company Product Application Footprint
3.7 Competitive Environment
3.7.1 Historical Structure of the Industry
3.7.2 Barriers of Market Entry
3.7.3 Factors of Competition
3.8 New Entrant and Capacity Expansion Plans
3.9 Mergers, Acquisition, Agreements, and Collaborations
4 UNITED STATES VS CHINA VS REST OF THE WORLD
4.1 United States VS China: Coagulation Factor IV Production Value Comparison
4.1.1 United States VS China: Coagulation Factor IV Production Value Comparison (2021 & 2025 & 2032)
4.1.2 United States VS China: Coagulation Factor IV Production Value Market Share Comparison (2021 & 2025 & 2032)
4.2 United States VS China: Coagulation Factor IV Production Comparison
4.2.1 United States VS China: Coagulation Factor IV Production Comparison (2021 & 2025 & 2032)
4.2.2 United States VS China: Coagulation Factor IV Production Market Share Comparison (2021 & 2025 & 2032)
4.3 United States VS China: Coagulation Factor IV Consumption Comparison
4.3.1 United States VS China: Coagulation Factor IV Consumption Comparison (2021 & 2025 & 2032)
4.3.2 United States VS China: Coagulation Factor IV Consumption Market Share Comparison (2021 & 2025 & 2032)
4.4 United States Based Coagulation Factor IV Manufacturers and Market Share, 2021-2026
4.4.1 United States Based Coagulation Factor IV Manufacturers, Headquarters and Production Site (States, Country)
4.4.2 United States Based Manufacturers Coagulation Factor IV Production Value (2021-2026)
4.4.3 United States Based Manufacturers Coagulation Factor IV Production (2021-2026)
4.5 China Based Coagulation Factor IV Manufacturers and Market Share
4.5.1 China Based Coagulation Factor IV Manufacturers, Headquarters and Production Site (Province, Country)
4.5.2 China Based Manufacturers Coagulation Factor IV Production Value (2021-2026)
4.5.3 China Based Manufacturers Coagulation Factor IV Production (2021-2026)
4.6 Rest of World Based Coagulation Factor IV Manufacturers and Market Share, 2021-2026
4.6.1 Rest of World Based Coagulation Factor IV Manufacturers, Headquarters and Production Site (State, Country)
4.6.2 Rest of World Based Manufacturers Coagulation Factor IV Production Value (2021-2026)
4.6.3 Rest of World Based Manufacturers Coagulation Factor IV Production (2021-2026)
5 MARKET ANALYSIS BY TYPE
5.1 World Coagulation Factor IV Market Size Overview by Type: 2021 VS 2025 VS 2032
5.2 Segment Introduction by Type
5.2.1 alcium Chloride-based Products
5.2.2 Calcium Gluconate-based Products
5.2.3 Others
5.3 Market Segment by Type
5.3.1 World Coagulation Factor IV Production by Type (2021-2032)
5.3.2 World Coagulation Factor IV Production Value by Type (2021-2032)
5.3.3 World Coagulation Factor IV Average Price by Type (2021-2032)
6 MARKET ANALYSIS BY PHARMACEUTICAL PRODUCT FORM
6.1 World Coagulation Factor IV Market Size Overview by Pharmaceutical Product Form: 2021 VS 2025 VS 2032
6.2 Segment Introduction by Pharmaceutical Product Form
6.2.1 Finished Drug Products
6.2.2 Hospital Preparations or Compounded Products
6.2.3 Others
6.3 Market Segment by Pharmaceutical Product Form
6.3.1 World Coagulation Factor IV Production by Pharmaceutical Product Form (2021-2032)
6.3.2 World Coagulation Factor IV Production Value by Pharmaceutical Product Form (2021-2032)
6.3.3 World Coagulation Factor IV Average Price by Pharmaceutical Product Form (2021-2032)
7 MARKET ANALYSIS BY SOLID MORPHOLOGY
7.1 World Coagulation Factor IV Market Size Overview by Solid Morphology: 2021 VS 2025 VS 2032
7.2 Segment Introduction by Solid Morphology
7.2.1 Powder or Crystalline Products
7.2.2 Granular Products
7.2.3 Flake Products
7.3 Market Segment by Solid Morphology
7.3.1 World Coagulation Factor IV Production by Solid Morphology (2021-2032)
7.3.2 World Coagulation Factor IV Production Value by Solid Morphology (2021-2032)
7.3.3 World Coagulation Factor IV Average Price by Solid Morphology (2021-2032)
8 MARKET ANALYSIS BY APPLICATION
8.1 World Coagulation Factor IV Market Size Overview by Application: 2021 VS 2025 VS 2032
8.2 Segment Introduction by Application
8.2.1 Hospital
8.2.2 Personal Clinic
8.2.3 Others
8.3 Market Segment by Application
8.3.1 World Coagulation Factor IV Production by Application (2021-2032)
8.3.2 World Coagulation Factor IV Production Value by Application (2021-2032)
8.3.3 World Coagulation Factor IV Average Price by Application (2021-2032)
9 COMPANY PROFILES
9.1 Pfizer
9.1.1 Pfizer Details
9.1.2 Pfizer Major Business
9.1.3 Pfizer Coagulation Factor IV Product and Services
9.1.4 Pfizer Coagulation Factor IV Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.1.5 Pfizer Recent Developments/Updates
9.1.6 Pfizer Competitive Strengths & Weaknesses
9.2 Baxter
9.2.1 Baxter Details
9.2.2 Baxter Major Business
9.2.3 Baxter Coagulation Factor IV Product and Services
9.2.4 Baxter Coagulation Factor IV Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.2.5 Baxter Recent Developments/Updates
9.2.6 Baxter Competitive Strengths & Weaknesses
9.3 Fresenius Kabi
9.3.1 Fresenius Kabi Details
9.3.2 Fresenius Kabi Major Business
9.3.3 Fresenius Kabi Coagulation Factor IV Product and Services
9.3.4 Fresenius Kabi Coagulation Factor IV Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.3.5 Fresenius Kabi Recent Developments/Updates
9.3.6 Fresenius Kabi Competitive Strengths & Weaknesses
9.4 B. Braun
9.4.1 B. Braun Details
9.4.2 B. Braun Major Business
9.4.3 B. Braun Coagulation Factor IV Product and Services
9.4.4 B. Braun Coagulation Factor IV Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.4.5 B. Braun Recent Developments/Updates
9.4.6 B. Braun Competitive Strengths & Weaknesses
9.5 Hikma
9.5.1 Hikma Details
9.5.2 Hikma Major Business
9.5.3 Hikma Coagulation Factor IV Product and Services
9.5.4 Hikma Coagulation Factor IV Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.5.5 Hikma Recent Developments/Updates
9.5.6 Hikma Competitive Strengths & Weaknesses
9.6 Amneal
9.6.1 Amneal Details
9.6.2 Amneal Major Business
9.6.3 Amneal Coagulation Factor IV Product and Services
9.6.4 Amneal Coagulation Factor IV Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.6.5 Amneal Recent Developments/Updates
9.6.6 Amneal Competitive Strengths & Weaknesses
9.7 Dr. Reddy’s
9.7.1 Dr. Reddy’s Details
9.7.2 Dr. Reddy’s Major Business
9.7.3 Dr. Reddy’s Coagulation Factor IV Product and Services
9.7.4 Dr. Reddy’s Coagulation Factor IV Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.7.5 Dr. Reddy’s Recent Developments/Updates
9.7.6 Dr. Reddy’s Competitive Strengths & Weaknesses
9.8 American Regent
9.8.1 American Regent Details
9.8.2 American Regent Major Business
9.8.3 American Regent Coagulation Factor IV Product and Services
9.8.4 American Regent Coagulation Factor IV Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.8.5 American Regent Recent Developments/Updates
9.8.6 American Regent Competitive Strengths & Weaknesses
9.9 Amphastar
9.9.1 Amphastar Details
9.9.2 Amphastar Major Business
9.9.3 Amphastar Coagulation Factor IV Product and Services
9.9.4 Amphastar Coagulation Factor IV Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.9.5 Amphastar Recent Developments/Updates
9.9.6 Amphastar Competitive Strengths & Weaknesses
9.10 Civica
9.10.1 Civica Details
9.10.2 Civica Major Business
9.10.3 Civica Coagulation Factor IV Product and Services
9.10.4 Civica Coagulation Factor IV Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.10.5 Civica Recent Developments/Updates
9.10.6 Civica Competitive Strengths & Weaknesses
9.11 hameln pharma
9.11.1 hameln pharma Details
9.11.2 hameln pharma Major Business
9.11.3 hameln pharma Coagulation Factor IV Product and Services
9.11.4 hameln pharma Coagulation Factor IV Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.11.5 hameln pharma Recent Developments/Updates
9.11.6 hameln pharma Competitive Strengths & Weaknesses
9.12 Medefil
9.12.1 Medefil Details
9.12.2 Medefil Major Business
9.12.3 Medefil Coagulation Factor IV Product and Services
9.12.4 Medefil Coagulation Factor IV Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.12.5 Medefil Recent Developments/Updates
9.12.6 Medefil Competitive Strengths & Weaknesses
9.13 OxyChem
9.13.1 OxyChem Details
9.13.2 OxyChem Major Business
9.13.3 OxyChem Coagulation Factor IV Product and Services
9.13.4 OxyChem Coagulation Factor IV Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.13.5 OxyChem Recent Developments/Updates
9.13.6 OxyChem Competitive Strengths & Weaknesses
9.14 TETRA Technologies
9.14.1 TETRA Technologies Details
9.14.2 TETRA Technologies Major Business
9.14.3 TETRA Technologies Coagulation Factor IV Product and Services
9.14.4 TETRA Technologies Coagulation Factor IV Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.14.5 TETRA Technologies Recent Developments/Updates
9.14.6 TETRA Technologies Competitive Strengths & Weaknesses
9.15 Tata Chemicals Europe
9.15.1 Tata Chemicals Europe Details
9.15.2 Tata Chemicals Europe Major Business
9.15.3 Tata Chemicals Europe Coagulation Factor IV Product and Services
9.15.4 Tata Chemicals Europe Coagulation Factor IV Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.15.5 Tata Chemicals Europe Recent Developments/Updates
9.15.6 Tata Chemicals Europe Competitive Strengths & Weaknesses
9.16 Zirax
9.16.1 Zirax Details
9.16.2 Zirax Major Business
9.16.3 Zirax Coagulation Factor IV Product and Services
9.16.4 Zirax Coagulation Factor IV Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.16.5 Zirax Recent Developments/Updates
9.16.6 Zirax Competitive Strengths & Weaknesses
9.17 Tokuyama
9.17.1 Tokuyama Details
9.17.2 Tokuyama Major Business
9.17.3 Tokuyama Coagulation Factor IV Product and Services
9.17.4 Tokuyama Coagulation Factor IV Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.17.5 Tokuyama Recent Developments/Updates
9.17.6 Tokuyama Competitive Strengths & Weaknesses
9.18 Merck KGaA
9.18.1 Merck KGaA Details
9.18.2 Merck KGaA Major Business
9.18.3 Merck KGaA Coagulation Factor IV Product and Services
9.18.4 Merck KGaA Coagulation Factor IV Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.18.5 Merck KGaA Recent Developments/Updates
9.18.6 Merck KGaA Competitive Strengths & Weaknesses
9.19 Thermo Fisher Scientific
9.19.1 Thermo Fisher Scientific Details
9.19.2 Thermo Fisher Scientific Major Business
9.19.3 Thermo Fisher Scientific Coagulation Factor IV Product and Services
9.19.4 Thermo Fisher Scientific Coagulation Factor IV Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.19.5 Thermo Fisher Scientific Recent Developments/Updates
9.19.6 Thermo Fisher Scientific Competitive Strengths & Weaknesses
9.20 Avantor
9.20.1 Avantor Details
9.20.2 Avantor Major Business
9.20.3 Avantor Coagulation Factor IV Product and Services
9.20.4 Avantor Coagulation Factor IV Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.20.5 Avantor Recent Developments/Updates
9.20.6 Avantor Competitive Strengths & Weaknesses
9.21 FUJIFILM Wako Pure Chemical
9.21.1 FUJIFILM Wako Pure Chemical Details
9.21.2 FUJIFILM Wako Pure Chemical Major Business
9.21.3 FUJIFILM Wako Pure Chemical Coagulation Factor IV Product and Services
9.21.4 FUJIFILM Wako Pure Chemical Coagulation Factor IV Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.21.5 FUJIFILM Wako Pure Chemical Recent Developments/Updates
9.21.6 FUJIFILM Wako Pure Chemical Competitive Strengths & Weaknesses
9.22 Tokyo Chemical Industry
9.22.1 Tokyo Chemical Industry Details
9.22.2 Tokyo Chemical Industry Major Business
9.22.3 Tokyo Chemical Industry Coagulation Factor IV Product and Services
9.22.4 Tokyo Chemical Industry Coagulation Factor IV Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.22.5 Tokyo Chemical Industry Recent Developments/Updates
9.22.6 Tokyo Chemical Industry Competitive Strengths & Weaknesses
9.23 Kanto Chemical
9.23.1 Kanto Chemical Details
9.23.2 Kanto Chemical Major Business
9.23.3 Kanto Chemical Coagulation Factor IV Product and Services
9.23.4 Kanto Chemical Coagulation Factor IV Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.23.5 Kanto Chemical Recent Developments/Updates
9.23.6 Kanto Chemical Competitive Strengths & Weaknesses
9.24 Nacalai Tesque
9.24.1 Nacalai Tesque Details
9.24.2 Nacalai Tesque Major Business
9.24.3 Nacalai Tesque Coagulation Factor IV Product and Services
9.24.4 Nacalai Tesque Coagulation Factor IV Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.24.5 Nacalai Tesque Recent Developments/Updates
9.24.6 Nacalai Tesque Competitive Strengths & Weaknesses
9.25 Spectrum Chemical
9.25.1 Spectrum Chemical Details
9.25.2 Spectrum Chemical Major Business
9.25.3 Spectrum Chemical Coagulation Factor IV Product and Services
9.25.4 Spectrum Chemical Coagulation Factor IV Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.25.5 Spectrum Chemical Recent Developments/Updates
9.25.6 Spectrum Chemical Competitive Strengths & Weaknesses
9.26 American Elements
9.26.1 American Elements Details
9.26.2 American Elements Major Business
9.26.3 American Elements Coagulation Factor IV Product and Services
9.26.4 American Elements Coagulation Factor IV Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.26.5 American Elements Recent Developments/Updates
9.26.6 American Elements Competitive Strengths & Weaknesses
9.27 Columbus Chemical Industries
9.27.1 Columbus Chemical Industries Details
9.27.2 Columbus Chemical Industries Major Business
9.27.3 Columbus Chemical Industries Coagulation Factor IV Product and Services
9.27.4 Columbus Chemical Industries Coagulation Factor IV Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.27.5 Columbus Chemical Industries Recent Developments/Updates
9.27.6 Columbus Chemical Industries Competitive Strengths & Weaknesses
9.28 Zhejiang Ruibang Pharmaceutical
9.28.1 Zhejiang Ruibang Pharmaceutical Details
9.28.2 Zhejiang Ruibang Pharmaceutical Major Business
9.28.3 Zhejiang Ruibang Pharmaceutical Coagulation Factor IV Product and Services
9.28.4 Zhejiang Ruibang Pharmaceutical Coagulation Factor IV Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.28.5 Zhejiang Ruibang Pharmaceutical Recent Developments/Updates
9.28.6 Zhejiang Ruibang Pharmaceutical Competitive Strengths & Weaknesses
9.29 Hebei Tiancheng Pharmaceutical
9.29.1 Hebei Tiancheng Pharmaceutical Details
9.29.2 Hebei Tiancheng Pharmaceutical Major Business
9.29.3 Hebei Tiancheng Pharmaceutical Coagulation Factor IV Product and Services
9.29.4 Hebei Tiancheng Pharmaceutical Coagulation Factor IV Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.29.5 Hebei Tiancheng Pharmaceutical Recent Developments/Updates
9.29.6 Hebei Tiancheng Pharmaceutical Competitive Strengths & Weaknesses
9.30 CR Double-Crane Limin Pharmaceutical
9.30.1 CR Double-Crane Limin Pharmaceutical Details
9.30.2 CR Double-Crane Limin Pharmaceutical Major Business
9.30.3 CR Double-Crane Limin Pharmaceutical Coagulation Factor IV Product and Services
9.30.4 CR Double-Crane Limin Pharmaceutical Coagulation Factor IV Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.30.5 CR Double-Crane Limin Pharmaceutical Recent Developments/Updates
9.30.6 CR Double-Crane Limin Pharmaceutical Competitive Strengths & Weaknesses
9.31 Jiangsu Hengrui Pharmaceuticals
9.31.1 Jiangsu Hengrui Pharmaceuticals Details
9.31.2 Jiangsu Hengrui Pharmaceuticals Major Business
9.31.3 Jiangsu Hengrui Pharmaceuticals Coagulation Factor IV Product and Services
9.31.4 Jiangsu Hengrui Pharmaceuticals Coagulation Factor IV Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.31.5 Jiangsu Hengrui Pharmaceuticals Recent Developments/Updates
9.31.6 Jiangsu Hengrui Pharmaceuticals Competitive Strengths & Weaknesses
9.32 Shandong Haihua
9.32.1 Shandong Haihua Details
9.32.2 Shandong Haihua Major Business
9.32.3 Shandong Haihua Coagulation Factor IV Product and Services
9.32.4 Shandong Haihua Coagulation Factor IV Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.32.5 Shandong Haihua Recent Developments/Updates
9.32.6 Shandong Haihua Competitive Strengths & Weaknesses
9.33 Shandong Haihua New Materials
9.33.1 Shandong Haihua New Materials Details
9.33.2 Shandong Haihua New Materials Major Business
9.33.3 Shandong Haihua New Materials Coagulation Factor IV Product and Services
9.33.4 Shandong Haihua New Materials Coagulation Factor IV Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.33.5 Shandong Haihua New Materials Recent Developments/Updates
9.33.6 Shandong Haihua New Materials Competitive Strengths & Weaknesses
10 INDUSTRY CHAIN ANALYSIS
10.1 Coagulation Factor IV Industry Chain
10.2 Coagulation Factor IV Upstream Analysis
10.2.1 Coagulation Factor IV Core Raw Materials
10.2.2 Main Manufacturers of Coagulation Factor IV Core Raw Materials
10.3 Midstream Analysis
10.4 Downstream Analysis
10.5 Coagulation Factor IV Production Mode
10.6 Coagulation Factor IV Procurement Model
10.7 Coagulation Factor IV Industry Sales Model and Sales Channels
10.7.1 Coagulation Factor IV Sales Model
10.7.2 Coagulation Factor IV Typical Distributors
11 RESEARCH FINDINGS AND CONCLUSION
12 APPENDIX
12.1 Methodology
12.2 Research Process and Data Source
12.3 Disclaimer
LIST OF TABLES
Table 1. World Coagulation Factor IV Production Value by Region (2021, 2025 and 2032) & (USD Million)
Table 2. World Coagulation Factor IV Production Value by Region (2021-2026) & (USD Million)
Table 3. World Coagulation Factor IV Production Value by Region (2027-2032) & (USD Million)
Table 4. World Coagulation Factor IV Production Value Market Share by Region (2021-2026)
Table 5. World Coagulation Factor IV Production Value Market Share by Region (2027-2032)
Table 6. World Coagulation Factor IV Production by Region (2021-2026) & (K Dose)
Table 7. World Coagulation Factor IV Production by Region (2027-2032) & (K Dose)
Table 8. World Coagulation Factor IV Production Market Share by Region (2021-2026)
Table 9. World Coagulation Factor IV Production Market Share by Region (2027-2032)
Table 10. World Coagulation Factor IV Average Price by Region (2021-2026) & (USD/Pcs)
Table 11. World Coagulation Factor IV Average Price by Region (2027-2032) & (USD/Pcs)
Table 12. Coagulation Factor IV Major Market Trends
Table 13. World Coagulation Factor IV Consumption Growth Rate Forecast by Region (2021 & 2025 & 2032) & (K Dose)
Table 14. World Coagulation Factor IV Consumption by Region (2021-2026) & (K Dose)
Table 15. World Coagulation Factor IV Consumption Forecast by Region (2027-2032) & (K Dose)
Table 16. World Coagulation Factor IV Production Value by Manufacturer (2021-2026) & (USD Million)
Table 17. Production Value Market Share of Key Coagulation Factor IV Producers in 2025
Table 18. World Coagulation Factor IV Production by Manufacturer (2021-2026) & (K Dose)
Table 19. Production Market Share of Key Coagulation Factor IV Producers in 2025
Table 20. World Coagulation Factor IV Average Price by Manufacturer (2021-2026) & (USD/Pcs)
Table 21. Global Coagulation Factor IV Company Evaluation Quadrant
Table 22. World Coagulation Factor IV Industry Rank of Major Manufacturers, Based on Production Value in 2025
Table 23. Head Office and Coagulation Factor IV Production Site of Key Manufacturer
Table 24. Coagulation Factor IV Market: Company Product Type Footprint
Table 25. Coagulation Factor IV Market: Company Product Application Footprint
Table 26. Coagulation Factor IV Competitive Factors
Table 27. Coagulation Factor IV New Entrant and Capacity Expansion Plans
Table 28. Coagulation Factor IV Mergers & Acquisitions Activity
Table 29. United States VS China Coagulation Factor IV Production Value Comparison, (2021 & 2025 & 2032) & (USD Million)
Table 30. United States VS China Coagulation Factor IV Production Comparison, (2021 & 2025 & 2032) & (K Dose)
Table 31. United States VS China Coagulation Factor IV Consumption Comparison, (2021 & 2025 & 2032) & (K Dose)
Table 32. United States Based Coagulation Factor IV Manufacturers, Headquarters and Production Site (States, Country)
Table 33. United States Based Manufacturers Coagulation Factor IV Production Value, (2021-2026) & (USD Million)
Table 34. United States Based Manufacturers Coagulation Factor IV Production Value Market Share (2021-2026)
Table 35. United States Based Manufacturers Coagulation Factor IV Production (2021-2026) & (K Dose)
Table 36. United States Based Manufacturers Coagulation Factor IV Production Market Share (2021-2026)
Table 37. China Based Coagulation Factor IV Manufacturers, Headquarters and Production Site (Province, Country)
Table 38. China Based Manufacturers Coagulation Factor IV Production Value, (2021-2026) & (USD Million)
Table 39. China Based Manufacturers Coagulation Factor IV Production Value Market Share (2021-2026)
Table 40. China Based Manufacturers Coagulation Factor IV Production, (2021-2026) & (K Dose)
Table 41. China Based Manufacturers Coagulation Factor IV Production Market Share (2021-2026)
Table 42. Rest of World Based Coagulation Factor IV Manufacturers, Headquarters and Production Site (State, Country)
Table 43. Rest of World Based Manufacturers Coagulation Factor IV Production Value, (2021-2026) & (USD Million)
Table 44. Rest of World Based Manufacturers Coagulation Factor IV Production Value Market Share (2021-2026)
Table 45. Rest of World Based Manufacturers Coagulation Factor IV Production, (2021-2026) & (K Dose)
Table 46. Rest of World Based Manufacturers Coagulation Factor IV Production Market Share (2021-2026)
Table 47. World Coagulation Factor IV Production Value by Type, (USD Million), 2021 & 2025 & 2032
Table 48. World Coagulation Factor IV Production by Type (2021-2026) & (K Dose)
Table 49. World Coagulation Factor IV Production by Type (2027-2032) & (K Dose)
Table 50. World Coagulation Factor IV Production Value by Type (2021-2026) & (USD Million)
Table 51. World Coagulation Factor IV Production Value by Type (2027-2032) & (USD Million)
Table 52. World Coagulation Factor IV Average Price by Type (2021-2026) & (USD/Pcs)
Table 53. World Coagulation Factor IV Average Price by Type (2027-2032) & (USD/Pcs)
Table 54. World Coagulation Factor IV Production Value by Pharmaceutical Product Form, (USD Million), 2021 & 2025 & 2032
Table 55. World Coagulation Factor IV Production by Pharmaceutical Product Form (2021-2026) & (K Dose)
Table 56. World Coagulation Factor IV Production by Pharmaceutical Product Form (2027-2032) & (K Dose)
Table 57. World Coagulation Factor IV Production Value by Pharmaceutical Product Form (2021-2026) & (USD Million)
Table 58. World Coagulation Factor IV Production Value by Pharmaceutical Product Form (2027-2032) & (USD Million)
Table 59. World Coagulation Factor IV Average Price by Pharmaceutical Product Form (2021-2026) & (USD/Pcs)
Table 60. World Coagulation Factor IV Average Price by Pharmaceutical Product Form (2027-2032) & (USD/Pcs)
Table 61. World Coagulation Factor IV Production Value by Solid Morphology, (USD Million), 2021 & 2025 & 2032
Table 62. World Coagulation Factor IV Production by Solid Morphology (2021-2026) & (K Dose)
Table 63. World Coagulation Factor IV Production by Solid Morphology (2027-2032) & (K Dose)
Table 64. World Coagulation Factor IV Production Value by Solid Morphology (2021-2026) & (USD Million)
Table 65. World Coagulation Factor IV Production Value by Solid Morphology (2027-2032) & (USD Million)
Table 66. World Coagulation Factor IV Average Price by Solid Morphology (2021-2026) & (USD/Pcs)
Table 67. World Coagulation Factor IV Average Price by Solid Morphology (2027-2032) & (USD/Pcs)
Table 68. World Coagulation Factor IV Production Value by Application, (USD Million), 2021 & 2025 & 2032
Table 69. World Coagulation Factor IV Production by Application (2021-2026) & (K Dose)
Table 70. World Coagulation Factor IV Production by Application (2027-2032) & (K Dose)
Table 71. World Coagulation Factor IV Production Value by Application (2021-2026) & (USD Million)
Table 72. World Coagulation Factor IV Production Value by Application (2027-2032) & (USD Million)
Table 73. World Coagulation Factor IV Average Price by Application (2021-2026) & (USD/Pcs)
Table 74. World Coagulation Factor IV Average Price by Application (2027-2032) & (USD/Pcs)
Table 75. Pfizer Basic Information, Manufacturing Base and Competitors
Table 76. Pfizer Major Business
Table 77. Pfizer Coagulation Factor IV Product and Services
Table 78. Pfizer Coagulation Factor IV Production (K Dose), Price (USD/Pcs), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 79. Pfizer Recent Developments/Updates
Table 80. Pfizer Competitive Strengths & Weaknesses
Table 81. Baxter Basic Information, Manufacturing Base and Competitors
Table 82. Baxter Major Business
Table 83. Baxter Coagulation Factor IV Product and Services
Table 84. Baxter Coagulation Factor IV Production (K Dose), Price (USD/Pcs), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 85. Baxter Recent Developments/Updates
Table 86. Baxter Competitive Strengths & Weaknesses
Table 87. Fresenius Kabi Basic Information, Manufacturing Base and Competitors
Table 88. Fresenius Kabi Major Business
Table 89. Fresenius Kabi Coagulation Factor IV Product and Services
Table 90. Fresenius Kabi Coagulation Factor IV Production (K Dose), Price (USD/Pcs), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 91. Fresenius Kabi Recent Developments/Updates
Table 92. Fresenius Kabi Competitive Strengths & Weaknesses
Table 93. B. Braun Basic Information, Manufacturing Base and Competitors
Table 94. B. Braun Major Business
Table 95. B. Braun Coagulation Factor IV Product and Services
Table 96. B. Braun Coagulation Factor IV Production (K Dose), Price (USD/Pcs), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 97. B. Braun Recent Developments/Updates
Table 98. B. Braun Competitive Strengths & Weaknesses
Table 99. Hikma Basic Information, Manufacturing Base and Competitors
Table 100. Hikma Major Business
Table 101. Hikma Coagulation Factor IV Product and Services
Table 102. Hikma Coagulation Factor IV Production (K Dose), Price (USD/Pcs), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 103. Hikma Recent Developments/Updates
Table 104. Hikma Competitive Strengths & Weaknesses
Table 105. Amneal Basic Information, Manufacturing Base and Competitors
Table 106. Amneal Major Business
Table 107. Amneal Coagulation Factor IV Product and Services
Table 108. Amneal Coagulation Factor IV Production (K Dose), Price (USD/Pcs), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 109. Amneal Recent Developments/Updates
Table 110. Amneal Competitive Strengths & Weaknesses
Table 111. Dr. Reddy’s Basic Information, Manufacturing Base and Competitors
Table 112. Dr. Reddy’s Major Business
Table 113. Dr. Reddy’s Coagulation Factor IV Product and Services
Table 114. Dr. Reddy’s Coagulation Factor IV Production (K Dose), Price (USD/Pcs), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 115. Dr. Reddy’s Recent Developments/Updates
Table 116. Dr. Reddy’s Competitive Strengths & Weaknesses
Table 117. American Regent Basic Information, Manufacturing Base and Competitors
Table 118. American Regent Major Business
Table 119. American Regent Coagulation Factor IV Product and Services
Table 120. American Regent Coagulation Factor IV Production (K Dose), Price (USD/Pcs), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 121. American Regent Recent Developments/Updates
Table 122. American Regent Competitive Strengths & Weaknesses
Table 123. Amphastar Basic Information, Manufacturing Base and Competitors
Table 124. Amphastar Major Business
Table 125. Amphastar Coagulation Factor IV Product and Services
Table 126. Amphastar Coagulation Factor IV Production (K Dose), Price (USD/Pcs), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 127. Amphastar Recent Developments/Updates
Table 128. Amphastar Competitive Strengths & Weaknesses
Table 129. Civica Basic Information, Manufacturing Base and Competitors
Table 130. Civica Major Business
Table 131. Civica Coagulation Factor IV Product and Services
Table 132. Civica Coagulation Factor IV Production (K Dose), Price (USD/Pcs), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 133. Civica Recent Developments/Updates
Table 134. Civica Competitive Strengths & Weaknesses
Table 135. hameln pharma Basic Information, Manufacturing Base and Competitors
Table 136. hameln pharma Major Business
Table 137. hameln pharma Coagulation Factor IV Product and Services
Table 138. hameln pharma Coagulation Factor IV Production (K Dose), Price (USD/Pcs), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 139. hameln pharma Recent Developments/Updates
Table 140. hameln pharma Competitive Strengths & Weaknesses
Table 141. Medefil Basic Information, Manufacturing Base and Competitors
Table 142. Medefil Major Business
Table 143. Medefil Coagulation Factor IV Product and Services
Table 144. Medefil Coagulation Factor IV Production (K Dose), Price (USD/Pcs), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 145. Medefil Recent Developments/Updates
Table 146. Medefil Competitive Strengths & Weaknesses
Table 147. OxyChem Basic Information, Manufacturing Base and Competitors
Table 148. OxyChem Major Business
Table 149. OxyChem Coagulation Factor IV Product and Services
Table 150. OxyChem Coagulation Factor IV Production (K Dose), Price (USD/Pcs), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 151. OxyChem Recent Developments/Updates
Table 152. OxyChem Competitive Strengths & Weaknesses
Table 153. TETRA Technologies Basic Information, Manufacturing Base and Competitors
Table 154. TETRA Technologies Major Business
Table 155. TETRA Technologies Coagulation Factor IV Product and Services
Table 156. TETRA Technologies Coagulation Factor IV Production (K Dose), Price (USD/Pcs), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 157. TETRA Technologies Recent Developments/Updates
Table 158. TETRA Technologies Competitive Strengths & Weaknesses
Table 159. Tata Chemicals Europe Basic Information, Manufacturing Base and Competitors
Table 160. Tata Chemicals Europe Major Business
Table 161. Tata Chemicals Europe Coagulation Factor IV Product and Services
Table 162. Tata Chemicals Europe Coagulation Factor IV Production (K Dose), Price (USD/Pcs), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 163. Tata Chemicals Europe Recent Developments/Updates
Table 164. Tata Chemicals Europe Competitive Strengths & Weaknesses
Table 165. Zirax Basic Information, Manufacturing Base and Competitors
Table 166. Zirax Major Business
Table 167. Zirax Coagulation Factor IV Product and Services
Table 168. Zirax Coagulation Factor IV Production (K Dose), Price (USD/Pcs), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 169. Zirax Recent Developments/Updates
Table 170. Zirax Competitive Strengths & Weaknesses
Table 171. Tokuyama Basic Information, Manufacturing Base and Competitors
Table 172. Tokuyama Major Business
Table 173. Tokuyama Coagulation Factor IV Product and Services
Table 174. Tokuyama Coagulation Factor IV Production (K Dose), Price (USD/Pcs), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 175. Tokuyama Recent Developments/Updates
Table 176. Tokuyama Competitive Strengths & Weaknesses
Table 177. Merck KGaA Basic Information, Manufacturing Base and Competitors
Table 178. Merck KGaA Major Business
Table 179. Merck KGaA Coagulation Factor IV Product and Services
Table 180. Merck KGaA Coagulation Factor IV Production (K Dose), Price (USD/Pcs), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 181. Merck KGaA Recent Developments/Updates
Table 182. Merck KGaA Competitive Strengths & Weaknesses
Table 183. Thermo Fisher Scientific Basic Information, Manufacturing Base and Competitors
Table 184. Thermo Fisher Scientific Major Business
Table 185. Thermo Fisher Scientific Coagulation Factor IV Product and Services
Table 186. Thermo Fisher Scientific Coagulation Factor IV Production (K Dose), Price (USD/Pcs), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 187. Thermo Fisher Scientific Recent Developments/Updates
Table 188. Thermo Fisher Scientific Competitive Strengths & Weaknesses
Table 189. Avantor Basic Information, Manufacturing Base and Competitors
Table 190. Avantor Major Business
Table 191. Avantor Coagulation Factor IV Product and Services
Table 192. Avantor Coagulation Factor IV Production (K Dose), Price (USD/Pcs), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 193. Avantor Recent Developments/Updates
Table 194. Avantor Competitive Strengths & Weaknesses
Table 195. FUJIFILM Wako Pure Chemical Basic Information, Manufacturing Base and Competitors
Table 196. FUJIFILM Wako Pure Chemical Major Business
Table 197. FUJIFILM Wako Pure Chemical Coagulation Factor IV Product and Services
Table 198. FUJIFILM Wako Pure Chemical Coagulation Factor IV Production (K Dose), Price (USD/Pcs), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 199. FUJIFILM Wako Pure Chemical Recent Developments/Updates
Table 200. FUJIFILM Wako Pure Chemical Competitive Strengths & Weaknesses
Table 201. Tokyo Chemical Industry Basic Information, Manufacturing Base and Competitors
Table 202. Tokyo Chemical Industry Major Business
Table 203. Tokyo Chemical Industry Coagulation Factor IV Product and Services
Table 204. Tokyo Chemical Industry Coagulation Factor IV Production (K Dose), Price (USD/Pcs), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 205. Tokyo Chemical Industry Recent Developments/Updates
Table 206. Tokyo Chemical Industry Competitive Strengths & Weaknesses
Table 207. Kanto Chemical Basic Information, Manufacturing Base and Competitors
Table 208. Kanto Chemical Major Business
Table 209. Kanto Chemical Coagulation Factor IV Product and Services
Table 210. Kanto Chemical Coagulation Factor IV Production (K Dose), Price (USD/Pcs), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 211. Kanto Chemical Recent Developments/Updates
Table 212. Kanto Chemical Competitive Strengths & Weaknesses
Table 213. Nacalai Tesque Basic Information, Manufacturing Base and Competitors
Table 214. Nacalai Tesque Major Business
Table 215. Nacalai Tesque Coagulation Factor IV Product and Services
Table 216. Nacalai Tesque Coagulation Factor IV Production (K Dose), Price (USD/Pcs), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 217. Nacalai Tesque Recent Developments/Updates
Table 218. Nacalai Tesque Competitive Strengths & Weaknesses
Table 219. Spectrum Chemical Basic Information, Manufacturing Base and Competitors
Table 220. Spectrum Chemical Major Business
Table 221. Spectrum Chemical Coagulation Factor IV Product and Services
Table 222. Spectrum Chemical Coagulation Factor IV Production (K Dose), Price (USD/Pcs), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 223. Spectrum Chemical Recent Developments/Updates
Table 224. Spectrum Chemical Competitive Strengths & Weaknesses
Table 225. American Elements Basic Information, Manufacturing Base and Competitors
Table 226. American Elements Major Business
Table 227. American Elements Coagulation Factor IV Product and Services
Table 228. American Elements Coagulation Factor IV Production (K Dose), Price (USD/Pcs), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 229. American Elements Recent Developments/Updates
Table 230. American Elements Competitive Strengths & Weaknesses
Table 231. Columbus Chemical Industries Basic Information, Manufacturing Base and Competitors
Table 232. Columbus Chemical Industries Major Business
Table 233. Columbus Chemical Industries Coagulation Factor IV Product and Services
Table 234. Columbus Chemical Industries Coagulation Factor IV Production (K Dose), Price (USD/Pcs), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 235. Columbus Chemical Industries Recent Developments/Updates
Table 236. Columbus Chemical Industries Competitive Strengths & Weaknesses
Table 237. Zhejiang Ruibang Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 238. Zhejiang Ruibang Pharmaceutical Major Business
Table 239. Zhejiang Ruibang Pharmaceutical Coagulation Factor IV Product and Services
Table 240. Zhejiang Ruibang Pharmaceutical Coagulation Factor IV Production (K Dose), Price (USD/Pcs), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 241. Zhejiang Ruibang Pharmaceutical Recent Developments/Updates
Table 242. Zhejiang Ruibang Pharmaceutical Competitive Strengths & Weaknesses
Table 243. Hebei Tiancheng Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 244. Hebei Tiancheng Pharmaceutical Major Business
Table 245. Hebei Tiancheng Pharmaceutical Coagulation Factor IV Product and Services
Table 246. Hebei Tiancheng Pharmaceutical Coagulation Factor IV Production (K Dose), Price (USD/Pcs), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 247. Hebei Tiancheng Pharmaceutical Recent Developments/Updates
Table 248. Hebei Tiancheng Pharmaceutical Competitive Strengths & Weaknesses
Table 249. CR Double-Crane Limin Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 250. CR Double-Crane Limin Pharmaceutical Major Business
Table 251. CR Double-Crane Limin Pharmaceutical Coagulation Factor IV Product and Services
Table 252. CR Double-Crane Limin Pharmaceutical Coagulation Factor IV Production (K Dose), Price (USD/Pcs), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 253. CR Double-Crane Limin Pharmaceutical Recent Developments/Updates
Table 254. CR Double-Crane Limin Pharmaceutical Competitive Strengths & Weaknesses
Table 255. Jiangsu Hengrui Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 256. Jiangsu Hengrui Pharmaceuticals Major Business
Table 257. Jiangsu Hengrui Pharmaceuticals Coagulation Factor IV Product and Services
Table 258. Jiangsu Hengrui Pharmaceuticals Coagulation Factor IV Production (K Dose), Price (USD/Pcs), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 259. Jiangsu Hengrui Pharmaceuticals Recent Developments/Updates
Table 260. Jiangsu Hengrui Pharmaceuticals Competitive Strengths & Weaknesses
Table 261. Shandong Haihua Basic Information, Manufacturing Base and Competitors
Table 262. Shandong Haihua Major Business
Table 263. Shandong Haihua Coagulation Factor IV Product and Services
Table 264. Shandong Haihua Coagulation Factor IV Production (K Dose), Price (USD/Pcs), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 265. Shandong Haihua Recent Developments/Updates
Table 266. Shandong Haihua Competitive Strengths & Weaknesses
Table 267. Shandong Haihua New Materials Basic Information, Manufacturing Base and Competitors
Table 268. Shandong Haihua New Materials Major Business
Table 269. Shandong Haihua New Materials Coagulation Factor IV Product and Services
Table 270. Shandong Haihua New Materials Coagulation Factor IV Production (K Dose), Price (USD/Pcs), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 271. Shandong Haihua New Materials Recent Developments/Updates
Table 272. Shandong Haihua New Materials Competitive Strengths & Weaknesses
Table 273. Global Key Players of Coagulation Factor IV Upstream (Raw Materials)
Table 274. Global Coagulation Factor IV Typical Customers
Table 275. Coagulation Factor IV Typical Distributors
Table 1. World Coagulation Factor IV Production Value by Region (2021, 2025 and 2032) & (USD Million)
Table 2. World Coagulation Factor IV Production Value by Region (2021-2026) & (USD Million)
Table 3. World Coagulation Factor IV Production Value by Region (2027-2032) & (USD Million)
Table 4. World Coagulation Factor IV Production Value Market Share by Region (2021-2026)
Table 5. World Coagulation Factor IV Production Value Market Share by Region (2027-2032)
Table 6. World Coagulation Factor IV Production by Region (2021-2026) & (K Dose)
Table 7. World Coagulation Factor IV Production by Region (2027-2032) & (K Dose)
Table 8. World Coagulation Factor IV Production Market Share by Region (2021-2026)
Table 9. World Coagulation Factor IV Production Market Share by Region (2027-2032)
Table 10. World Coagulation Factor IV Average Price by Region (2021-2026) & (USD/Pcs)
Table 11. World Coagulation Factor IV Average Price by Region (2027-2032) & (USD/Pcs)
Table 12. Coagulation Factor IV Major Market Trends
Table 13. World Coagulation Factor IV Consumption Growth Rate Forecast by Region (2021 & 2025 & 2032) & (K Dose)
Table 14. World Coagulation Factor IV Consumption by Region (2021-2026) & (K Dose)
Table 15. World Coagulation Factor IV Consumption Forecast by Region (2027-2032) & (K Dose)
Table 16. World Coagulation Factor IV Production Value by Manufacturer (2021-2026) & (USD Million)
Table 17. Production Value Market Share of Key Coagulation Factor IV Producers in 2025
Table 18. World Coagulation Factor IV Production by Manufacturer (2021-2026) & (K Dose)
Table 19. Production Market Share of Key Coagulation Factor IV Producers in 2025
Table 20. World Coagulation Factor IV Average Price by Manufacturer (2021-2026) & (USD/Pcs)
Table 21. Global Coagulation Factor IV Company Evaluation Quadrant
Table 22. World Coagulation Factor IV Industry Rank of Major Manufacturers, Based on Production Value in 2025
Table 23. Head Office and Coagulation Factor IV Production Site of Key Manufacturer
Table 24. Coagulation Factor IV Market: Company Product Type Footprint
Table 25. Coagulation Factor IV Market: Company Product Application Footprint
Table 26. Coagulation Factor IV Competitive Factors
Table 27. Coagulation Factor IV New Entrant and Capacity Expansion Plans
Table 28. Coagulation Factor IV Mergers & Acquisitions Activity
Table 29. United States VS China Coagulation Factor IV Production Value Comparison, (2021 & 2025 & 2032) & (USD Million)
Table 30. United States VS China Coagulation Factor IV Production Comparison, (2021 & 2025 & 2032) & (K Dose)
Table 31. United States VS China Coagulation Factor IV Consumption Comparison, (2021 & 2025 & 2032) & (K Dose)
Table 32. United States Based Coagulation Factor IV Manufacturers, Headquarters and Production Site (States, Country)
Table 33. United States Based Manufacturers Coagulation Factor IV Production Value, (2021-2026) & (USD Million)
Table 34. United States Based Manufacturers Coagulation Factor IV Production Value Market Share (2021-2026)
Table 35. United States Based Manufacturers Coagulation Factor IV Production (2021-2026) & (K Dose)
Table 36. United States Based Manufacturers Coagulation Factor IV Production Market Share (2021-2026)
Table 37. China Based Coagulation Factor IV Manufacturers, Headquarters and Production Site (Province, Country)
Table 38. China Based Manufacturers Coagulation Factor IV Production Value, (2021-2026) & (USD Million)
Table 39. China Based Manufacturers Coagulation Factor IV Production Value Market Share (2021-2026)
Table 40. China Based Manufacturers Coagulation Factor IV Production, (2021-2026) & (K Dose)
Table 41. China Based Manufacturers Coagulation Factor IV Production Market Share (2021-2026)
Table 42. Rest of World Based Coagulation Factor IV Manufacturers, Headquarters and Production Site (State, Country)
Table 43. Rest of World Based Manufacturers Coagulation Factor IV Production Value, (2021-2026) & (USD Million)
Table 44. Rest of World Based Manufacturers Coagulation Factor IV Production Value Market Share (2021-2026)
Table 45. Rest of World Based Manufacturers Coagulation Factor IV Production, (2021-2026) & (K Dose)
Table 46. Rest of World Based Manufacturers Coagulation Factor IV Production Market Share (2021-2026)
Table 47. World Coagulation Factor IV Production Value by Type, (USD Million), 2021 & 2025 & 2032
Table 48. World Coagulation Factor IV Production by Type (2021-2026) & (K Dose)
Table 49. World Coagulation Factor IV Production by Type (2027-2032) & (K Dose)
Table 50. World Coagulation Factor IV Production Value by Type (2021-2026) & (USD Million)
Table 51. World Coagulation Factor IV Production Value by Type (2027-2032) & (USD Million)
Table 52. World Coagulation Factor IV Average Price by Type (2021-2026) & (USD/Pcs)
Table 53. World Coagulation Factor IV Average Price by Type (2027-2032) & (USD/Pcs)
Table 54. World Coagulation Factor IV Production Value by Pharmaceutical Product Form, (USD Million), 2021 & 2025 & 2032
Table 55. World Coagulation Factor IV Production by Pharmaceutical Product Form (2021-2026) & (K Dose)
Table 56. World Coagulation Factor IV Production by Pharmaceutical Product Form (2027-2032) & (K Dose)
Table 57. World Coagulation Factor IV Production Value by Pharmaceutical Product Form (2021-2026) & (USD Million)
Table 58. World Coagulation Factor IV Production Value by Pharmaceutical Product Form (2027-2032) & (USD Million)
Table 59. World Coagulation Factor IV Average Price by Pharmaceutical Product Form (2021-2026) & (USD/Pcs)
Table 60. World Coagulation Factor IV Average Price by Pharmaceutical Product Form (2027-2032) & (USD/Pcs)
Table 61. World Coagulation Factor IV Production Value by Solid Morphology, (USD Million), 2021 & 2025 & 2032
Table 62. World Coagulation Factor IV Production by Solid Morphology (2021-2026) & (K Dose)
Table 63. World Coagulation Factor IV Production by Solid Morphology (2027-2032) & (K Dose)
Table 64. World Coagulation Factor IV Production Value by Solid Morphology (2021-2026) & (USD Million)
Table 65. World Coagulation Factor IV Production Value by Solid Morphology (2027-2032) & (USD Million)
Table 66. World Coagulation Factor IV Average Price by Solid Morphology (2021-2026) & (USD/Pcs)
Table 67. World Coagulation Factor IV Average Price by Solid Morphology (2027-2032) & (USD/Pcs)
Table 68. World Coagulation Factor IV Production Value by Application, (USD Million), 2021 & 2025 & 2032
Table 69. World Coagulation Factor IV Production by Application (2021-2026) & (K Dose)
Table 70. World Coagulation Factor IV Production by Application (2027-2032) & (K Dose)
Table 71. World Coagulation Factor IV Production Value by Application (2021-2026) & (USD Million)
Table 72. World Coagulation Factor IV Production Value by Application (2027-2032) & (USD Million)
Table 73. World Coagulation Factor IV Average Price by Application (2021-2026) & (USD/Pcs)
Table 74. World Coagulation Factor IV Average Price by Application (2027-2032) & (USD/Pcs)
Table 75. Pfizer Basic Information, Manufacturing Base and Competitors
Table 76. Pfizer Major Business
Table 77. Pfizer Coagulation Factor IV Product and Services
Table 78. Pfizer Coagulation Factor IV Production (K Dose), Price (USD/Pcs), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 79. Pfizer Recent Developments/Updates
Table 80. Pfizer Competitive Strengths & Weaknesses
Table 81. Baxter Basic Information, Manufacturing Base and Competitors
Table 82. Baxter Major Business
Table 83. Baxter Coagulation Factor IV Product and Services
Table 84. Baxter Coagulation Factor IV Production (K Dose), Price (USD/Pcs), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 85. Baxter Recent Developments/Updates
Table 86. Baxter Competitive Strengths & Weaknesses
Table 87. Fresenius Kabi Basic Information, Manufacturing Base and Competitors
Table 88. Fresenius Kabi Major Business
Table 89. Fresenius Kabi Coagulation Factor IV Product and Services
Table 90. Fresenius Kabi Coagulation Factor IV Production (K Dose), Price (USD/Pcs), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 91. Fresenius Kabi Recent Developments/Updates
Table 92. Fresenius Kabi Competitive Strengths & Weaknesses
Table 93. B. Braun Basic Information, Manufacturing Base and Competitors
Table 94. B. Braun Major Business
Table 95. B. Braun Coagulation Factor IV Product and Services
Table 96. B. Braun Coagulation Factor IV Production (K Dose), Price (USD/Pcs), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 97. B. Braun Recent Developments/Updates
Table 98. B. Braun Competitive Strengths & Weaknesses
Table 99. Hikma Basic Information, Manufacturing Base and Competitors
Table 100. Hikma Major Business
Table 101. Hikma Coagulation Factor IV Product and Services
Table 102. Hikma Coagulation Factor IV Production (K Dose), Price (USD/Pcs), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 103. Hikma Recent Developments/Updates
Table 104. Hikma Competitive Strengths & Weaknesses
Table 105. Amneal Basic Information, Manufacturing Base and Competitors
Table 106. Amneal Major Business
Table 107. Amneal Coagulation Factor IV Product and Services
Table 108. Amneal Coagulation Factor IV Production (K Dose), Price (USD/Pcs), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 109. Amneal Recent Developments/Updates
Table 110. Amneal Competitive Strengths & Weaknesses
Table 111. Dr. Reddy’s Basic Information, Manufacturing Base and Competitors
Table 112. Dr. Reddy’s Major Business
Table 113. Dr. Reddy’s Coagulation Factor IV Product and Services
Table 114. Dr. Reddy’s Coagulation Factor IV Production (K Dose), Price (USD/Pcs), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 115. Dr. Reddy’s Recent Developments/Updates
Table 116. Dr. Reddy’s Competitive Strengths & Weaknesses
Table 117. American Regent Basic Information, Manufacturing Base and Competitors
Table 118. American Regent Major Business
Table 119. American Regent Coagulation Factor IV Product and Services
Table 120. American Regent Coagulation Factor IV Production (K Dose), Price (USD/Pcs), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 121. American Regent Recent Developments/Updates
Table 122. American Regent Competitive Strengths & Weaknesses
Table 123. Amphastar Basic Information, Manufacturing Base and Competitors
Table 124. Amphastar Major Business
Table 125. Amphastar Coagulation Factor IV Product and Services
Table 126. Amphastar Coagulation Factor IV Production (K Dose), Price (USD/Pcs), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 127. Amphastar Recent Developments/Updates
Table 128. Amphastar Competitive Strengths & Weaknesses
Table 129. Civica Basic Information, Manufacturing Base and Competitors
Table 130. Civica Major Business
Table 131. Civica Coagulation Factor IV Product and Services
Table 132. Civica Coagulation Factor IV Production (K Dose), Price (USD/Pcs), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 133. Civica Recent Developments/Updates
Table 134. Civica Competitive Strengths & Weaknesses
Table 135. hameln pharma Basic Information, Manufacturing Base and Competitors
Table 136. hameln pharma Major Business
Table 137. hameln pharma Coagulation Factor IV Product and Services
Table 138. hameln pharma Coagulation Factor IV Production (K Dose), Price (USD/Pcs), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 139. hameln pharma Recent Developments/Updates
Table 140. hameln pharma Competitive Strengths & Weaknesses
Table 141. Medefil Basic Information, Manufacturing Base and Competitors
Table 142. Medefil Major Business
Table 143. Medefil Coagulation Factor IV Product and Services
Table 144. Medefil Coagulation Factor IV Production (K Dose), Price (USD/Pcs), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 145. Medefil Recent Developments/Updates
Table 146. Medefil Competitive Strengths & Weaknesses
Table 147. OxyChem Basic Information, Manufacturing Base and Competitors
Table 148. OxyChem Major Business
Table 149. OxyChem Coagulation Factor IV Product and Services
Table 150. OxyChem Coagulation Factor IV Production (K Dose), Price (USD/Pcs), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 151. OxyChem Recent Developments/Updates
Table 152. OxyChem Competitive Strengths & Weaknesses
Table 153. TETRA Technologies Basic Information, Manufacturing Base and Competitors
Table 154. TETRA Technologies Major Business
Table 155. TETRA Technologies Coagulation Factor IV Product and Services
Table 156. TETRA Technologies Coagulation Factor IV Production (K Dose), Price (USD/Pcs), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 157. TETRA Technologies Recent Developments/Updates
Table 158. TETRA Technologies Competitive Strengths & Weaknesses
Table 159. Tata Chemicals Europe Basic Information, Manufacturing Base and Competitors
Table 160. Tata Chemicals Europe Major Business
Table 161. Tata Chemicals Europe Coagulation Factor IV Product and Services
Table 162. Tata Chemicals Europe Coagulation Factor IV Production (K Dose), Price (USD/Pcs), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 163. Tata Chemicals Europe Recent Developments/Updates
Table 164. Tata Chemicals Europe Competitive Strengths & Weaknesses
Table 165. Zirax Basic Information, Manufacturing Base and Competitors
Table 166. Zirax Major Business
Table 167. Zirax Coagulation Factor IV Product and Services
Table 168. Zirax Coagulation Factor IV Production (K Dose), Price (USD/Pcs), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 169. Zirax Recent Developments/Updates
Table 170. Zirax Competitive Strengths & Weaknesses
Table 171. Tokuyama Basic Information, Manufacturing Base and Competitors
Table 172. Tokuyama Major Business
Table 173. Tokuyama Coagulation Factor IV Product and Services
Table 174. Tokuyama Coagulation Factor IV Production (K Dose), Price (USD/Pcs), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 175. Tokuyama Recent Developments/Updates
Table 176. Tokuyama Competitive Strengths & Weaknesses
Table 177. Merck KGaA Basic Information, Manufacturing Base and Competitors
Table 178. Merck KGaA Major Business
Table 179. Merck KGaA Coagulation Factor IV Product and Services
Table 180. Merck KGaA Coagulation Factor IV Production (K Dose), Price (USD/Pcs), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 181. Merck KGaA Recent Developments/Updates
Table 182. Merck KGaA Competitive Strengths & Weaknesses
Table 183. Thermo Fisher Scientific Basic Information, Manufacturing Base and Competitors
Table 184. Thermo Fisher Scientific Major Business
Table 185. Thermo Fisher Scientific Coagulation Factor IV Product and Services
Table 186. Thermo Fisher Scientific Coagulation Factor IV Production (K Dose), Price (USD/Pcs), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 187. Thermo Fisher Scientific Recent Developments/Updates
Table 188. Thermo Fisher Scientific Competitive Strengths & Weaknesses
Table 189. Avantor Basic Information, Manufacturing Base and Competitors
Table 190. Avantor Major Business
Table 191. Avantor Coagulation Factor IV Product and Services
Table 192. Avantor Coagulation Factor IV Production (K Dose), Price (USD/Pcs), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 193. Avantor Recent Developments/Updates
Table 194. Avantor Competitive Strengths & Weaknesses
Table 195. FUJIFILM Wako Pure Chemical Basic Information, Manufacturing Base and Competitors
Table 196. FUJIFILM Wako Pure Chemical Major Business
Table 197. FUJIFILM Wako Pure Chemical Coagulation Factor IV Product and Services
Table 198. FUJIFILM Wako Pure Chemical Coagulation Factor IV Production (K Dose), Price (USD/Pcs), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 199. FUJIFILM Wako Pure Chemical Recent Developments/Updates
Table 200. FUJIFILM Wako Pure Chemical Competitive Strengths & Weaknesses
Table 201. Tokyo Chemical Industry Basic Information, Manufacturing Base and Competitors
Table 202. Tokyo Chemical Industry Major Business
Table 203. Tokyo Chemical Industry Coagulation Factor IV Product and Services
Table 204. Tokyo Chemical Industry Coagulation Factor IV Production (K Dose), Price (USD/Pcs), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 205. Tokyo Chemical Industry Recent Developments/Updates
Table 206. Tokyo Chemical Industry Competitive Strengths & Weaknesses
Table 207. Kanto Chemical Basic Information, Manufacturing Base and Competitors
Table 208. Kanto Chemical Major Business
Table 209. Kanto Chemical Coagulation Factor IV Product and Services
Table 210. Kanto Chemical Coagulation Factor IV Production (K Dose), Price (USD/Pcs), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 211. Kanto Chemical Recent Developments/Updates
Table 212. Kanto Chemical Competitive Strengths & Weaknesses
Table 213. Nacalai Tesque Basic Information, Manufacturing Base and Competitors
Table 214. Nacalai Tesque Major Business
Table 215. Nacalai Tesque Coagulation Factor IV Product and Services
Table 216. Nacalai Tesque Coagulation Factor IV Production (K Dose), Price (USD/Pcs), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 217. Nacalai Tesque Recent Developments/Updates
Table 218. Nacalai Tesque Competitive Strengths & Weaknesses
Table 219. Spectrum Chemical Basic Information, Manufacturing Base and Competitors
Table 220. Spectrum Chemical Major Business
Table 221. Spectrum Chemical Coagulation Factor IV Product and Services
Table 222. Spectrum Chemical Coagulation Factor IV Production (K Dose), Price (USD/Pcs), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 223. Spectrum Chemical Recent Developments/Updates
Table 224. Spectrum Chemical Competitive Strengths & Weaknesses
Table 225. American Elements Basic Information, Manufacturing Base and Competitors
Table 226. American Elements Major Business
Table 227. American Elements Coagulation Factor IV Product and Services
Table 228. American Elements Coagulation Factor IV Production (K Dose), Price (USD/Pcs), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 229. American Elements Recent Developments/Updates
Table 230. American Elements Competitive Strengths & Weaknesses
Table 231. Columbus Chemical Industries Basic Information, Manufacturing Base and Competitors
Table 232. Columbus Chemical Industries Major Business
Table 233. Columbus Chemical Industries Coagulation Factor IV Product and Services
Table 234. Columbus Chemical Industries Coagulation Factor IV Production (K Dose), Price (USD/Pcs), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 235. Columbus Chemical Industries Recent Developments/Updates
Table 236. Columbus Chemical Industries Competitive Strengths & Weaknesses
Table 237. Zhejiang Ruibang Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 238. Zhejiang Ruibang Pharmaceutical Major Business
Table 239. Zhejiang Ruibang Pharmaceutical Coagulation Factor IV Product and Services
Table 240. Zhejiang Ruibang Pharmaceutical Coagulation Factor IV Production (K Dose), Price (USD/Pcs), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 241. Zhejiang Ruibang Pharmaceutical Recent Developments/Updates
Table 242. Zhejiang Ruibang Pharmaceutical Competitive Strengths & Weaknesses
Table 243. Hebei Tiancheng Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 244. Hebei Tiancheng Pharmaceutical Major Business
Table 245. Hebei Tiancheng Pharmaceutical Coagulation Factor IV Product and Services
Table 246. Hebei Tiancheng Pharmaceutical Coagulation Factor IV Production (K Dose), Price (USD/Pcs), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 247. Hebei Tiancheng Pharmaceutical Recent Developments/Updates
Table 248. Hebei Tiancheng Pharmaceutical Competitive Strengths & Weaknesses
Table 249. CR Double-Crane Limin Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 250. CR Double-Crane Limin Pharmaceutical Major Business
Table 251. CR Double-Crane Limin Pharmaceutical Coagulation Factor IV Product and Services
Table 252. CR Double-Crane Limin Pharmaceutical Coagulation Factor IV Production (K Dose), Price (USD/Pcs), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 253. CR Double-Crane Limin Pharmaceutical Recent Developments/Updates
Table 254. CR Double-Crane Limin Pharmaceutical Competitive Strengths & Weaknesses
Table 255. Jiangsu Hengrui Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 256. Jiangsu Hengrui Pharmaceuticals Major Business
Table 257. Jiangsu Hengrui Pharmaceuticals Coagulation Factor IV Product and Services
Table 258. Jiangsu Hengrui Pharmaceuticals Coagulation Factor IV Production (K Dose), Price (USD/Pcs), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 259. Jiangsu Hengrui Pharmaceuticals Recent Developments/Updates
Table 260. Jiangsu Hengrui Pharmaceuticals Competitive Strengths & Weaknesses
Table 261. Shandong Haihua Basic Information, Manufacturing Base and Competitors
Table 262. Shandong Haihua Major Business
Table 263. Shandong Haihua Coagulation Factor IV Product and Services
Table 264. Shandong Haihua Coagulation Factor IV Production (K Dose), Price (USD/Pcs), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 265. Shandong Haihua Recent Developments/Updates
Table 266. Shandong Haihua Competitive Strengths & Weaknesses
Table 267. Shandong Haihua New Materials Basic Information, Manufacturing Base and Competitors
Table 268. Shandong Haihua New Materials Major Business
Table 269. Shandong Haihua New Materials Coagulation Factor IV Product and Services
Table 270. Shandong Haihua New Materials Coagulation Factor IV Production (K Dose), Price (USD/Pcs), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 271. Shandong Haihua New Materials Recent Developments/Updates
Table 272. Shandong Haihua New Materials Competitive Strengths & Weaknesses
Table 273. Global Key Players of Coagulation Factor IV Upstream (Raw Materials)
Table 274. Global Coagulation Factor IV Typical Customers
Table 275. Coagulation Factor IV Typical Distributors
LIST OF FIGURES
Figure 1. Coagulation Factor IV Picture
Figure 2. World Coagulation Factor IV Production Value: 2021 & 2025 & 2032, (USD Million)
Figure 3. World Coagulation Factor IV Production Value and Forecast (2021-2032) & (USD Million)
Figure 4. World Coagulation Factor IV Production (2021-2032) & (K Dose)
Figure 5. World Coagulation Factor IV Average Price (2021-2032) & (USD/Pcs)
Figure 6. World Coagulation Factor IV Production Value Market Share by Region (2021-2032)
Figure 7. World Coagulation Factor IV Production Market Share by Region (2021-2032)
Figure 8. North America Coagulation Factor IV Production (2021-2032) & (K Dose)
Figure 9. Europe Coagulation Factor IV Production (2021-2032) & (K Dose)
Figure 10. China Coagulation Factor IV Production (2021-2032) & (K Dose)
Figure 11. Japan Coagulation Factor IV Production (2021-2032) & (K Dose)
Figure 12. India Coagulation Factor IV Production (2021-2032) & (K Dose)
Figure 13. Southeast Asia Coagulation Factor IV Production (2021-2032) & (K Dose)
Figure 14. Coagulation Factor IV Market Drivers
Figure 15. Factors Affecting Demand
Figure 16. World Coagulation Factor IV Consumption (2021-2032) & (K Dose)
Figure 17. World Coagulation Factor IV Consumption Market Share by Region (2021-2032)
Figure 18. United States Coagulation Factor IV Consumption (2021-2032) & (K Dose)
Figure 19. China Coagulation Factor IV Consumption (2021-2032) & (K Dose)
Figure 20. Europe Coagulation Factor IV Consumption (2021-2032) & (K Dose)
Figure 21. Japan Coagulation Factor IV Consumption (2021-2032) & (K Dose)
Figure 22. South Korea Coagulation Factor IV Consumption (2021-2032) & (K Dose)
Figure 23. ASEAN Coagulation Factor IV Consumption (2021-2032) & (K Dose)
Figure 24. India Coagulation Factor IV Consumption (2021-2032) & (K Dose)
Figure 25. Producer Shipments of Coagulation Factor IV by Manufacturer Revenue ($MM) and Market Share (%): 2025
Figure 26. Global Four-firm Concentration Ratios (CR4) for Coagulation Factor IV Markets in 2025
Figure 27. Global Four-firm Concentration Ratios (CR8) for Coagulation Factor IV Markets in 2025
Figure 28. United States VS China: Coagulation Factor IV Production Value Market Share Comparison (2021 & 2025 & 2032)
Figure 29. United States VS China: Coagulation Factor IV Production Market Share Comparison (2021 & 2025 & 2032)
Figure 30. United States VS China: Coagulation Factor IV Consumption Market Share Comparison (2021 & 2025 & 2032)
Figure 31. United States Based Manufacturers Coagulation Factor IV Production Market Share 2025
Figure 32. China Based Manufacturers Coagulation Factor IV Production Market Share 2025
Figure 33. Rest of World Based Manufacturers Coagulation Factor IV Production Market Share 2025
Figure 34. World Coagulation Factor IV Production Value by Type, (USD Million), 2021 & 2025 & 2032
Figure 35. World Coagulation Factor IV Production Value Market Share by Type in 2025
Figure 36. alcium Chloride-based Products
Figure 37. Calcium Gluconate-based Products
Figure 38. Others
Figure 39. World Coagulation Factor IV Production Market Share by Type (2021-2032)
Figure 40. World Coagulation Factor IV Production Value Market Share by Type (2021-2032)
Figure 41. World Coagulation Factor IV Average Price by Type (2021-2032) & (USD/Pcs)
Figure 42. World Coagulation Factor IV Production Value by Pharmaceutical Product Form, (USD Million), 2021 & 2025 & 2032
Figure 43. World Coagulation Factor IV Production Value Market Share by Pharmaceutical Product Form in 2025
Figure 44. Finished Drug Products
Figure 45. Hospital Preparations or Compounded Products
Figure 46. Others
Figure 47. World Coagulation Factor IV Production Market Share by Pharmaceutical Product Form (2021-2032)
Figure 48. World Coagulation Factor IV Production Value Market Share by Pharmaceutical Product Form (2021-2032)
Figure 49. World Coagulation Factor IV Average Price by Pharmaceutical Product Form (2021-2032) & (USD/Pcs)
Figure 50. World Coagulation Factor IV Production Value by Solid Morphology, (USD Million), 2021 & 2025 & 2032
Figure 51. World Coagulation Factor IV Production Value Market Share by Solid Morphology in 2025
Figure 52. Powder or Crystalline Products
Figure 53. Granular Products
Figure 54. Flake Products
Figure 55. World Coagulation Factor IV Production Market Share by Solid Morphology (2021-2032)
Figure 56. World Coagulation Factor IV Production Value Market Share by Solid Morphology (2021-2032)
Figure 57. World Coagulation Factor IV Average Price by Solid Morphology (2021-2032) & (USD/Pcs)
Figure 58. World Coagulation Factor IV Production Value by Application, (USD Million), 2021 & 2025 & 2032
Figure 59. World Coagulation Factor IV Production Value Market Share by Application in 2025
Figure 60. Hospital
Figure 61. Personal Clinic
Figure 62. Others
Figure 63. World Coagulation Factor IV Production Market Share by Application (2021-2032)
Figure 64. World Coagulation Factor IV Production Value Market Share by Application (2021-2032)
Figure 65. World Coagulation Factor IV Average Price by Application (2021-2032) & (USD/Pcs)
Figure 66. Coagulation Factor IV Industry Chain
Figure 67. Coagulation Factor IV Procurement Model
Figure 68. Coagulation Factor IV Sales Model
Figure 69. Coagulation Factor IV Sales Channels, Direct Sales, and Distribution
Figure 70. Methodology
Figure 71. Research Process and Data Source
Figure 1. Coagulation Factor IV Picture
Figure 2. World Coagulation Factor IV Production Value: 2021 & 2025 & 2032, (USD Million)
Figure 3. World Coagulation Factor IV Production Value and Forecast (2021-2032) & (USD Million)
Figure 4. World Coagulation Factor IV Production (2021-2032) & (K Dose)
Figure 5. World Coagulation Factor IV Average Price (2021-2032) & (USD/Pcs)
Figure 6. World Coagulation Factor IV Production Value Market Share by Region (2021-2032)
Figure 7. World Coagulation Factor IV Production Market Share by Region (2021-2032)
Figure 8. North America Coagulation Factor IV Production (2021-2032) & (K Dose)
Figure 9. Europe Coagulation Factor IV Production (2021-2032) & (K Dose)
Figure 10. China Coagulation Factor IV Production (2021-2032) & (K Dose)
Figure 11. Japan Coagulation Factor IV Production (2021-2032) & (K Dose)
Figure 12. India Coagulation Factor IV Production (2021-2032) & (K Dose)
Figure 13. Southeast Asia Coagulation Factor IV Production (2021-2032) & (K Dose)
Figure 14. Coagulation Factor IV Market Drivers
Figure 15. Factors Affecting Demand
Figure 16. World Coagulation Factor IV Consumption (2021-2032) & (K Dose)
Figure 17. World Coagulation Factor IV Consumption Market Share by Region (2021-2032)
Figure 18. United States Coagulation Factor IV Consumption (2021-2032) & (K Dose)
Figure 19. China Coagulation Factor IV Consumption (2021-2032) & (K Dose)
Figure 20. Europe Coagulation Factor IV Consumption (2021-2032) & (K Dose)
Figure 21. Japan Coagulation Factor IV Consumption (2021-2032) & (K Dose)
Figure 22. South Korea Coagulation Factor IV Consumption (2021-2032) & (K Dose)
Figure 23. ASEAN Coagulation Factor IV Consumption (2021-2032) & (K Dose)
Figure 24. India Coagulation Factor IV Consumption (2021-2032) & (K Dose)
Figure 25. Producer Shipments of Coagulation Factor IV by Manufacturer Revenue ($MM) and Market Share (%): 2025
Figure 26. Global Four-firm Concentration Ratios (CR4) for Coagulation Factor IV Markets in 2025
Figure 27. Global Four-firm Concentration Ratios (CR8) for Coagulation Factor IV Markets in 2025
Figure 28. United States VS China: Coagulation Factor IV Production Value Market Share Comparison (2021 & 2025 & 2032)
Figure 29. United States VS China: Coagulation Factor IV Production Market Share Comparison (2021 & 2025 & 2032)
Figure 30. United States VS China: Coagulation Factor IV Consumption Market Share Comparison (2021 & 2025 & 2032)
Figure 31. United States Based Manufacturers Coagulation Factor IV Production Market Share 2025
Figure 32. China Based Manufacturers Coagulation Factor IV Production Market Share 2025
Figure 33. Rest of World Based Manufacturers Coagulation Factor IV Production Market Share 2025
Figure 34. World Coagulation Factor IV Production Value by Type, (USD Million), 2021 & 2025 & 2032
Figure 35. World Coagulation Factor IV Production Value Market Share by Type in 2025
Figure 36. alcium Chloride-based Products
Figure 37. Calcium Gluconate-based Products
Figure 38. Others
Figure 39. World Coagulation Factor IV Production Market Share by Type (2021-2032)
Figure 40. World Coagulation Factor IV Production Value Market Share by Type (2021-2032)
Figure 41. World Coagulation Factor IV Average Price by Type (2021-2032) & (USD/Pcs)
Figure 42. World Coagulation Factor IV Production Value by Pharmaceutical Product Form, (USD Million), 2021 & 2025 & 2032
Figure 43. World Coagulation Factor IV Production Value Market Share by Pharmaceutical Product Form in 2025
Figure 44. Finished Drug Products
Figure 45. Hospital Preparations or Compounded Products
Figure 46. Others
Figure 47. World Coagulation Factor IV Production Market Share by Pharmaceutical Product Form (2021-2032)
Figure 48. World Coagulation Factor IV Production Value Market Share by Pharmaceutical Product Form (2021-2032)
Figure 49. World Coagulation Factor IV Average Price by Pharmaceutical Product Form (2021-2032) & (USD/Pcs)
Figure 50. World Coagulation Factor IV Production Value by Solid Morphology, (USD Million), 2021 & 2025 & 2032
Figure 51. World Coagulation Factor IV Production Value Market Share by Solid Morphology in 2025
Figure 52. Powder or Crystalline Products
Figure 53. Granular Products
Figure 54. Flake Products
Figure 55. World Coagulation Factor IV Production Market Share by Solid Morphology (2021-2032)
Figure 56. World Coagulation Factor IV Production Value Market Share by Solid Morphology (2021-2032)
Figure 57. World Coagulation Factor IV Average Price by Solid Morphology (2021-2032) & (USD/Pcs)
Figure 58. World Coagulation Factor IV Production Value by Application, (USD Million), 2021 & 2025 & 2032
Figure 59. World Coagulation Factor IV Production Value Market Share by Application in 2025
Figure 60. Hospital
Figure 61. Personal Clinic
Figure 62. Others
Figure 63. World Coagulation Factor IV Production Market Share by Application (2021-2032)
Figure 64. World Coagulation Factor IV Production Value Market Share by Application (2021-2032)
Figure 65. World Coagulation Factor IV Average Price by Application (2021-2032) & (USD/Pcs)
Figure 66. Coagulation Factor IV Industry Chain
Figure 67. Coagulation Factor IV Procurement Model
Figure 68. Coagulation Factor IV Sales Model
Figure 69. Coagulation Factor IV Sales Channels, Direct Sales, and Distribution
Figure 70. Methodology
Figure 71. Research Process and Data Source
